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3. Abstract 
The consequence of unrepaired damage could be very serious during embryonic 
development as it could transmit to the large populations of cells including germ lines 
subsequently leading to teratogenicity and/or embryonic lethality. Therefore, it is vital for 
early embryonic cells to respond efficiently to genotoxic stress through coordinated and 
integrated DNA damage repair pathways. 
The zygote and its daughter cells (2-cell-stage blastomeres) are the only known 
totipotent cells as they are capable of generating an entire organism while inner cell mass 
(ICM)-derived embryonic stem cells (ESC) are regarded as pluripotent because they have 
the ability to contribute to embryonic but not extra-embryonic tissues. Recent studies have 
identified 2C-like cells (also known as metastable state) as a rare transient cell population 
(~1-5%) within mouse embryonic (ESC) and induced pluripotent stem cell (iPSC) cultures 
that express high levels of transcripts also found in totipotent two-cell (2C) embryos. 
Notably, nearly all cultured PSCs cycle in and out of this metastable state, at least once 
during nine passages that is also accompanied by the transient transcriptional activation of 
2C-spesific genes including MuERV-L and Zscan4. Interestingly, the remarkable genomic 
stability of mouse pluripotent stem cells has been recently linked to the transient bursts of 
Zscan4 (a well-known 2C marker) expression during this metastable state. Zscan4 
knockdown in PSC shortens telomeres, increases karyotype abnormalities and spontaneous 
sister chromatid exchanges that subsequently leads to crisis by passage eight. These 
findings suggest that transition to 2C-like state in PSC culture is critical to maintain the 
genomic stability of these cells. 
Although the extended developmental potential of 2C-like cells in generating 
embryonic plus extra-embryonic tissues as well as their higher reprogrammability through 
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SCNT assay has been explored by several groups, the molecular mechanism underlying the 
transition to 2C-like cells is not well understood. Recent reports show that cultured ESCs 
and mouse embryos suffer from Ataxia telangiectasia and Rad3 related (ATR) dependent 
constitutive replication stress which is associated with H2AX phosphorylation and 
chromatin loading of the ssDNA-binding proteins RPA and RAD51. Hence, given the 
importance of transition to 2C-like state for maintaining ESC genome stability, I 
hypothesized whether the transition into the metastable state is regulated through activation 
of DNA damage signaling pathways. Here, I found that ATR mediated DNA replication 
stress response triggers transition to 2C-like state in ESC.  Importantly, through activation 
of DNA replication stress response, PSC exhibit functional and transcriptional features of 
2C-like state. Overall our finding suggests a novel ATR dependent transcriptional 
regulation that ensures genomic integrity during a period of extreme proliferation and 
differentiation.   
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4. Introduction 
4.1. Early mouse embryo development 
4.1.1. Pre-implantation mouse embryo development 
The first phase of embryonic development from fertilization till blastocyst 
formation, so-called pre-implantation stage is of immense importance for mammalian life 
since it is carefully orchestrated sequence of events that makes the first cell fate decisions. 
During pre-implantation period, embryo progressively develops more differentiated cells at 
the expense of more restricted developmental potency.  
Upon fertilization, diploid one-cell (1C) embryo which is denoted a Zygote is 
produced. Few hours later, the first mitotic division of the zygote occurs which cleaves the 
1C embryo to two identical daughter cells. The zygote and its daughter cells (2-cell-stage 
blastomeres) are the only known totipotent cells (by definition), which can generate an 
entire organism (Macfarlan, Gifford et al. 2012, Ishiuchi, Enriquez-Gasca et al. 2015, Zhou 
and Dean 2015). After two more rounds of cleavage, the 8-cell embryo is followed by 
compaction and polarization of the cells either toward inner or outer part of the embryo 
through symmetric and/or asymmetric cell divisions to form morula that by embryonic day 
3.5 (E3.5) develops to the blastocyst (Chazaud and Yamanaka 2016). Blastocyst is an oval 
shaped structure with a fluid-filled cavity named blastocoel consisting of two distinct cell 
types namely inner cell mass (ICM) and Trophectoderm (TE). ICM and Trophectoderm 
have different transcriptional signature. While Octamer 4 (Oct4), Nanog, and SRY- box 
containing gene 2 (Sox2) play an essential role in the establishment of pluripotency, TE 
cells development depend on Caudal type homeobox 2 (Cdx2) transcription factor 
(Strumpf, Mao et al. 2005, Thomson, Liu et al. 2011). Subsequently, ICM cells 
differentiate to epiblast cells (EPI), which in turn develop all three embryonic germ layers 
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of the fetus, namely Endoderm, Ectoderm and Mesoderm and also primitive endoderm 
(PrE) cells that express Gata4 and Gata6 and contribute to formation of yolk sac 
(Koutsourakis, Langeveld et al. 1999). TE plays a key role in implantation of the embryo 
into the uterus wall and it is precursor of placenta, an essential organ ensuring fetal 
development (Chazaud and Yamanaka 2016). Inner cell mass (ICM)-derived embryonic 
stem cells (ESC) are regarded as pluripotent because they have the ability to contribute to 
all embryonic lineages but not to TE and extra-embryonic tissues (Macfarlan, Gifford et al. 
2012, Ishiuchi, Enriquez-Gasca et al. 2015, Zhou and Dean 2015). At day 4.5 (E4.5) 
embryo fractures the surrounding zona pellucida (ZP) known as “hatching” and implants to 
the uterine to continue following phases of proper embryo development (Rossant and Tam 
2009). 
 
Fig 1.1.   Mouse preimplantation development and maternal-to-embryonic transition.  
After ovulation from the ovary into the oviduct, terminally differentiated mature eggs 
(surrounded by the extracellular zona pellucida) are fertilized by sperm to establish 
totipotent zygotes that divide during pre-implantation development to become blastocysts 
prior to implantation in the uterus at embryonic day 4.5. Upon fertilization, stored maternal 
factors activate the embryonic genome to trigger maternal-to-embryonic transition that 
results in formation of a totipotent zygote. Adapted from (Zhou and Dean 2015). 
 
4.1.2. Pluripotency  
4.1.2.1.ESC  
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Embryonic stem cells (ESC) are the first in vitro pluripotent cells that were derived 
from ICM of the blastocyst and established artificially by culturing them on inactivated 
mouse embryonic fibroblast (MEF) feeder layer, in the presence of leukemia inhibitory 
factor (LIF) to activate STAT3 and serum or bone morphogenetic protein (BMP) in order 
to inhibit differentiation and keep stemness of ESC. An alternative way to culture them is 
adaptation of ESC to feeder free condition. These cells resemble pluripotent features of 
epiblast cells in terms of unlimited self-renewal (maintenance of undifferentiated state) and 
differentiation toward three main embryonic lineages namely, endoderm, mesoderm and 
ectoderm (Evans and Kaufman 1981, Martin 1981, Niwa, Burdon et al. 1998, Ying, 
Nichols et al. 2003). The use of ESC is of great interest since they are immortal cells, 
which can proliferate infinitely with high speed.  
In 2008 Austin Smith group showed that inhibition of differentiation inducing 
signaling from mitogen-activated protein kinase/ERK kinase (MEK) and glycogen 
synthase kinase 3 (GSK3) in ESC culture are required to maintain their proper stemness 
and self-renewal properties. The sustained undifferentiated ESC state that is attained by 
using inhibitors of these two pathways (2i) in culture medium is called “ground state” 
which is more similar to in vivo pluripotent state (Sato, Meijer et al. 2004, Ying, Wray et 
al. 2008).  
  
 
 
 
 
Fig 1.2.  Inhibition of GSK3 serves a key function in augmenting self-renewal when 
phospho-ERK (p- ERK) is suppressed by maintaining cellular growth capacity.  
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Diagrams of self-replication of the pluripotent state when inductive phospho-ERK 
signaling is either inhibited upstream by chemical antagonists (left panel) or counteracted 
downstream by LIF and BMP (right panel). Adapted from (Ying, Wray et al. 2008). 
 
4.1.2.2.Application 
Due to infinite ability of ESC to self-renew but also their great potential of in vitro 
differentiation toward any desired epiblast-derived cell types (by providing the right signal 
transductions via defined growth factors at appropriate time), these cells could offer an 
endless pool of differentiated cell types. Thus, ESC could be considered as a robust and 
reliable physiological model for embryogenesis studies, drug discovery, patient-specific 
cell therapies and disease modeling in particular for diseases, affecting inaccessible cell 
types such as early embryonic stage cells or terminally differentiated cells, such as neural 
cells. That is why great efforts have been made in the past decade to establish the 
feasibility of using ESC for the above mentioned applications. However, despite 
substantial pros of using ESC over primary or immortalized cells, the usage of ESC are 
highly limited due to ethical debates following ESC derivation (Grskovic, Javaherian et al. 
2011).   
4.1.2.3.Somatic cell reprogramming to induced pluripotent stem cells (iPSC) 
For the first time in 2006, the seminal work of Shinya Yamanaka showed that 
through ectopic expression of four transcription factors, namely: Oct4, Sox2, Klf4 and c-
Myc, somatic cells can turn the developmental clock back and can be converted to 
embryonic stem cell-like state so called iPSCs in vitro, (Takahashi and Yamanaka 2006, 
Yamanaka 2012).  
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Fig 1.3.  Somatic cell reprograming was achieved by forced expression of four key 
transcription factors.  
Starting from a collection of 24 different transcription factors (symbolized by the test 
tube); (1), Takahashi and Yamanaka (2006) demonstrated that a set of only four 
transcription factors (Myc, Oct3/4, Sox2 and Klf4) was sufficient to convert cultured 
mouse embryonic or adult fibroblasts (2) to become pluripotent cells capable of producing 
teratomas in vivo and contributing to chimeric mice (3). The pluripotent cells were called 
induced pluripotent stem cells (iPS cells). Adapted from 
https://www.nobelprize.org/nobel_prizes/medicine/laureates/2012  
 
This achievement was established based on three different streams of previous 
research. The first stream was generation of tadpoles upon nuclear transfer of intestinal cell 
nuclei from adult Xenopus laevis into unfertilized egg that was reported by John Gurdon in 
1962 which is named somatic cell nuclear transfer (SCNT) (Gurdon 1962). Later Ian 
Wilmut consolidated this finding through generation of Dolly sheep, the first cloned 
mammal using the very same SCNT method upon nuclear transfer of mammary epithelial 
cells in to enucleated oocyte (Wilmut, Schnieke et al. 1997). 
The second stream was identifying the inducing role of transcription factors in 
formation of myocytes from fibroblast and transformation of antennae into second legs in 
Drosophila (Davis, Weintraub et al. 1987, Schneuwly, Klemenz et al. 1987). And 
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ultimately, the third stream was the isolation and establishment of ESC in culture condition 
(Davis, Weintraub et al. 1987, Smith, Heath et al. 1988).  
 
Fig. 1.4. Scientific streams led to or emerged from iPSC technology.  
A) Three scientific streams that led to the development of iPSCs. B) New scientific 
streams that emerged from the development of iPSCs. Adapted from (Yamanaka 2012).  
 
iPSC are not only comparable to ESC in terms of their morphology, transcriptional 
profile, epigenetic pattern and growth characteristics, but also, they can differentiate in 
vitro and in vivo to embryoid bodies and teratomas, respectively. Of note, similar to ESC, 
iPSC are capable of generating an entire mouse upon injection into the blastocyst of an 
embryo proving that they are indeed pluripotent (Takahashi and Yamanaka 2006). 
Therefore, this finding holds great promises for drug screening and regenerative therapies 
(Yamanaka 2012). 
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Fig 1.5. iPSC to model neurodegenerative and neurodevelopmental diseases. 
Human iPSC from neurologic patients and controls are generated after somatic tissue 
reprogramming (e.g. skin or blood cells). Neural progenitor cells (NPC) are generated and 
are further differentiated into neurons and/or glial cells. Neurons are then differentiated 
into subtypes of neurons such as dopaminergic, cholinergic, etc. Cellular phenotype is 
assessed by measuring neuronal morphology (i.e. process branching, spine 
density/size/maturation). Next, connectivity and circuitry integration can be analyzed by 
calcium influx transients, electrophysiology and trans-neuronal tracing with the rabies 
virus. In addition, the cross-talk between neurons and glia can be studied to tease out 
autonomous and non-autonomous aspects of the disease. Once a distinct disease-related 
phenotype is identified, drug-screening platforms can be developed to test compounds that 
improve cellular phenotype. Therapeutic compounds could emerge from the screenings, 
potentially benefiting neurologic patients. Adapted from (Marchetto, Winner et al. 2010). 
 
Marchetto M.	et	al.	Hum.	Mol.	Genet.	2010
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4.1.2.4. Limitation 
However, in spite of several investigations on iPSC studies, the great passion of 
using these cells for regenerative medicine is confined due to inefficient reprogramming, 
lack of reproducible and robust differentiation protocols of iPSC and finally the genetic 
and epigenetic abnormalities of iPSC in culture that overall hinder the potential use of 
these cells for regenerative therapies and clinical applications (Vitale, Matigian et al. 
2012). One of the key limitations of iPSC, is modeling diseases which occur at much 
primitive stage of embryonic development (prior to blastocyst stage). Similarly, the 
physiology of very early developmental stages cannot be studied via iPSC. Therefore, 
recently there is a great focus on establishment of cells with totipotnet-like features, which 
may present an additional opportunity for therapeutic purposes. 
 
4.1.3. Totipotency  
Totipotent cells (Zygote and its 2C blastomers) are the origin of all cells in the 
body since they are not only capable of differentiating in any cell type such as fetus 
embryonic three germ layers and all extra-embryonic tissues, but also, they can 
independently organize the developmental sequence to form a full organism without the 
need of carrier cells. (Macfarlan, Gifford et al. 2012, Condic 2014, Ishiuchi, Enriquez-
Gasca et al. 2015, Zhou and Dean 2015). Of note, cells in later stages of embryonic 
development (e.g., 4-cell and 8-cell phases) are not considered any more totipotent since 
they are more restricted in their developmental potency. 
Zygote has the minimal de novo transcript and it’s mainly supported by the 
maternal storage. After the first cleavage, the transcription significantly increases in 2C-
embryos that is called Zygote genome activation (ZGA). The newly synthesized ZGA 
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products progressively substitute the maternal storage to self-organize the early embryonic 
developmental events (Zhou and Dean 2015).   
 
4.1.3.1.2C-like cells 
Recent studies have identified 2C-like cells (also known as metastable state) as a 
rare transient sub-population of cells (~1-5%) within mouse embryonic (ESC) and induced 
pluripotent stem cell (iPSC) cultures that express high levels of transcripts also found in 
totipotent two-cell (2C) embryos (Zalzman, Falco et al. 2010, Macfarlan, Gifford et al. 
2012, Akiyama, Xin et al. 2015). Notably, nearly all PSCs cycle in and out of this 
metastable state, at least once during nine passages that is also accompanied by the 
fluctuating expression of some key 2C genes such as Zscan4 gene family and transient 
transcriptional activation of endogenous retroviruses (ERVs), in particular MuERV-L.  
 
4.1.3.2.Zscan4  
Zscan4 (zinc finger and SCAN domain containing 4) gene cluster in mouse 
accommodates six highly similar transcribed paralogous genes (Zscan4a–f) and three 
pseudogenes that are accordingly called Zscan4 (Falco, Lee et al. 2007). During pre-
implantation development Zscsn4 is exclusively expressed in 2C stage as it is not 
detectable in later stages and in blastocysts, but when blastocysts are cultured as an 
outgrowth, a few percentages of ICM derived ESC begin to express Zscan4. Remarkably, 
knocking down Zscan4 in two-cell embryos avoids the implantation to uterine wall due to 
one-day delay that occurs during embryonic development. Of note, Zscan4d is 
predominantly expressed in 2C-embryos while Zscan4c is mostly expressed in about 1-5% 
of ESC culture (Falco, Lee et al. 2007, Ko 2016). 
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Fig 1.6 The Zscan4 family.  
(A) Exon–intron structures of nine Zscan4 paralogs. New gene symbols proposed are 
shown in bold italics with the current gene symbols. (B) Putative protein structures of 
Zscan4 paralogs. Adapted from (Falco, Lee et al. 2007). 
 
Interestingly, the remarkable genomic stability of mouse pluripotent stem cells has 
been recently linked to the transient bursts of Zscan4 expression during this metastable 
state. Zscan4 knockdown in PSCs shortens telomeres, increases karyotype abnormalities 
and spontaneous sister chromatid exchanges that subsequently lead to crisis by passage 
eight. On the other hand, transient overexpression of Zscan4 promotes telomere sister 
chromatid exchange (T-SCE) and telomere recombination as it causes telomerase-
independent extension of telomere length in mouse ESC and decreases spontaneous SCE 
throughout the genome (Zalzman, Falco et al. 2010). These results overall suggest that 
transition to 2C-like state in PSC culture could be beneficial for proper proliferation and 
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also to maintain the genomic stability of these cells (Zalzman, Falco et al. 2010, Amano, 
Hirata et al. 2013).  
Though ESC are capable of maintaining their potential to generate an entire animal 
upon several passages in culture, it is known that the long-term culture may drop the 
efficiency of this process (Suda, Suzuki et al. 1987). Importantly, it has been demonstrated 
that ESC could sustain their high potency of chimeric mouse generation through frequent 
activation pulses of Zscan4, even in long-term culture conditions. Moreover, it has been 
found that sorted Zscan4+ cells have lower developmental potency with respect to Zscan4- 
population suggesting that although Zscan4+ state itself, lacks developmental potency, the 
reversible transition to Zscan4+ state is needed to rejuvenate ESC and recover their 
developmental potency (Amano, Jeffries et al. 2015). Of note, it is demonstrated that 
constitutive expression of Zscan4 leads to slowing down or blocking of proliferation in 
both MEF and ESC (Hirata, Amano et al. 2012). 
Furthermore, it is revealed that overexpression of Zscan4 together with 
conventional reprogramming factors not only could increase the somatic cell 
reprogramming efficiency, but also enhance the quality of formed iPSC as shown by 
tetraploid complementation assay. Importantly, Zscan4 expression, which transiently 
reactivates pre-implantation specific genes, is only needed for the first few days of 
reprogramming, while other reprogramming factors are not dispensable during entire 
reprogramming process (Hirata, Amano et al. 2012, Jiang, Lv et al. 2013).  
A recent study revealed that during transition from Zscan4- to Zscan4+ and vice 
versa (Zscan4-associated event; Z4 event) dynamic epigenetic changes arise in ESC, i.e. 
derepression of heterochromatin in Zscan4+ followed by rerepression upon switching to 
Zscan4- cells. Derepression of chromatin is accompanied by DNA demetylation, histone 
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acetylation (for instance H3K27ac) and a burst of transcription from typically silenced 
regions of the genome. This heterochromatin-based transcriptional activity suggests that 
mESCs may maintain their extraordinary genome stability at least in part by transiently 
resetting their heterochromatin (Akiyama, Xin et al. 2015). Several studies proved that in 
cancer cells the expression of heterochromatin genes e.g. retrotransposons through opening 
of heterochromatin regions of the genome and massive transcription from these sites 
threaten genomic integrity of cells and are dangerous for pre implantation development 
However, it is speculated that early embryos encounter this treat by transient blocking of 
global protein synthesis (please see section 4.1.3.3). (Egger, Liang et al. 2004, Ting, 
Lipson et al. 2011, Carone and Lawrence 2013, Ko 2016).  
Strikingly, two recent studies demonstrated that in Drosophila and Caenorhabditis 
elegans, substantial transcriptional activation during ZGA triggers intrinsic DNA damage 
and since keeping the genome integrity at very early stage of development is very critical 
for the embryo, having the capability of accurate repair mechanisms is of paramount value 
to avoid the transmission of mutations to the entire body or even next generation.  
 Therefore, it is reasonable to think that Zscan4 and other 2C related genes like Tcstv1&3 
are possibly activated to improve the genome stability of early embryonic cells. In 
particular, Zscan4 may increase homologous-recombination mediated-repair, which is the 
most accurate and precise repair mechanism that exists in germ cells as it has been shown 
that in Zscan4 positive ESC, meiosis-specific homologous recombination genes are 
upregulated (Tichy, Pillai et al. 2010, Zalzman, Falco et al. 2010, Blythe and Wieschaus 
2015, Butuci, Williams et al. 2015, Ko 2016).  
Aneuploidy of human pre-implantation embryos is an important concept that needs 
to be considered for failure of appropriate development of an embryo. However, several 
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works have recently reported healthy newborns despite aneuploidy diagnosis at much 
primitive stages of development possibly due to either selection or self-corrections 
mechanisms present in preimplantation embryos. Importantly, in vitro fertilization studies 
represent that karyotype abnormalities after ZGA in human embryos (day5) are much less 
than at day3 where ZGA has not occurred yet, suggesting that some ZGA-specific repair 
mechanisms might be involved in self correction of chromosomal abnormalities (Bazrgar, 
Gourabi et al. 2013, Ko 2016). Interestingly, Ko lab showed that not only transient 
overexpression of Zscan4 (one of the key ZGA genes) in mouse ESC improves their 
karyotypic features, but also it can correct karyotype abnormalities of human primary 
fibroblast cells derived from Down syndrome (Trisomy 21) and Edwards syndrome 
(Trisomy 18) patients (no mechanistic evidences on how this could happen is discussed in 
this paper) (Zalzman, Falco et al. 2010, Amano, Hirata et al. 2013, Amano, Jeffries et al. 
2015, Ko 2016). These evidences overall suggest that activation of Zscan4 and possibly 
some other two cell specific genes are important for the proper development of embryos .    
 
 
 
 
 
 
 
Fig 1.7. Expression profiles of Zscan4 in mouse preimplantation embryos and mouse 
ES cells.  
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(A) Whole-mount RNA in situ hybridization of mouse preimplantation embryos with a 
Zscan4 probe. (B) qRT-PCR analyses of Zscan4 expression during preimplantation 
development. (C) Whole-mount RNA in situ hybridization of mouse ES cell colonies with 
a Zscan4 probe. (D) As a control, whole-mount RNA in situ hybridization with Pou5fa 
(a.k.a. Oct3/4 or Oct4). (E) Structure of mouse Zscan4 protein (Zscan4c). Modified from 
(Falco, Lee et al. 2007, Ko 2016). 
 
4.1.3.3.Eif1a-like genes 
Eukaryotic translation initiation factor1A (Eif1a) is one of ZGA-specific genes that 
are transiently expressed in 2C embryos. However, recent studies showed that it is not 
EiF1a itself, but Eif1a-like genes, which are expressed in Zscan4+ cells and 2C-embryos. 
These genes may act as a dominant negative competitor of Eif1a, since their over 
expression could repress the global protein synthesis in mouse ESC during Z4 event. In 
particular it has been suggested that the expression of Eif1a-like genes could block the 
translation of the harmful genes to keep the genomic integrity of mouse ESC (Davis, 
DeSousa et al. 1996, Hung, Wong et al. 2013, Ko 2016). 
4.1.3.4.Tcstv1 and Tcstv3 
Tcstv1 (two-cell-stage, variable group, member 1) and Tcstv3 (two-cell-stage, 
variable group, member 3) are other two originally reported 2C-stage transcripts that when 
overexpressed, increase the expression of Zscan4 and regulate the length of telomeres. 
Therefore, they play an essential role in long-term maintenance of ESC (Zhang, Dan et al. 
2016).  
 
4.1.3.5.MuERV-L 
Murine endogenous retrovirus-like gene (MuERV-L) is highly abundant mRNA at 
the 2-cell stage of development but it undergoes repression through various epigenetic 
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silencing mechanisms at the blastocyst stage. Such a tight regulation is essential to keep 
the balance between destructive outcomes of retro-transpositions in the genome versus the 
benefits of promoting genetic diversity. Recent data indicate that MuERV-L regulates the 
unique transcriptional signature of both 2C-like cells and 2C-embryos through various 
mechanisms including; the activation of enhancers, introducing alternative promoters and 
generation of chimeric transcripts for early embryonic mouse genes. (Macfarlan, Gifford et 
al. 2011, Macfarlan, Gifford et al. 2012, Schoorlemmer, Perez-Palacios et al. 2014, 
Robbez-Masson and Rowe 2015, Zhou and Dean 2015). Besides this, MuERV-L positive 
2C-like PSC, are found to have more expanded developmental capacity, as they contribute 
to extra-embryonic tissues such as yolk sac, TE and placenta, in contrast to normal PSC 
which can only contribute to embryonic lineages (Macfarlan, Gifford et al. 2012). 
 
Fig 1.8. Retrotransposons are activated during the preimplantation stage 
and provide alternative first exons to activate downstream embryonic genes, producing 
chimeric transcripts that are absent in other cell types. Adapted from (Zhou and Dean 
2015). 
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4.1.3.6. Regulation of 2C-like cells in PSC culture 
Several genetic and culture related alterations have been shown to regulate the 
population of 2C like cells in ESC and iPSC culture. Here I summarize each study 
highlighting their main findings: 
4.1.3.6.1. Environmental factors: 
 Growing ESCs in 2i media (containing 3mM glycogen synthase kinase 3b 
(GSK3b) and mitogen-activated protein-kinase kinase (MEK) inhibitors) that is known as 
‘ground-state’ media condition drops the percentage of 2C-like cells in ESC culture in 
comparison to knock out serum (KOSR) or fetal calf serum (FCS) containing media. 
Moreover, culturing ESCs in 20% oxygen (O2) tension also has been found to increase the 
2C-like population in comparison to 5% O2 culture condition, suggesting some extrinsic 
and intrinsic regulatory mechanisms for expression of 2C specific genes in PSC culture. 
(Macfarlan, Gifford et al. 2012).  
  
4.1.3.6.2. Genetic factors 
Few studies attempted to identify key molecular players, linked to the transition 
from pluripotent to totipotent-like state. For instance, previous reports demonstrated that 
2C-specific genes were increased in mutant ES cells lacking the histone lysine-specific 
demethylase gene Kdm1a (also known as LSD1), chromatin assembly factor-1 (CAF-1), 
the H3K9 histone methyltranferase G9a, KRAB (Kruppel- associated box)-associated 
transcriptional repressor Kap1 and ten-eleven translocation (TET) proteins that will be 
discussed briefly below. (Macfarlan, Gifford et al. 2012, Maksakova, Thompson et al. 
2013, Rowe, Friedli et al. 2013, Lu, Liu et al. 2014, Ishiuchi, Enriquez-Gasca et al. 2015). 
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4.1.3.6.2.1.KAP1 
KAP1 is a member of the RBCC (ring, B-box, coiled–coiled) or TRIM (tripartite 
motif) family of proteins. It is recruited to genes by the tetrapod- specific, DNA sequence-
specific KRAB-ZFPs (Kruppel-associated box domain-zinc finger proteins) in vertebrates.  
Due to the fact that KAP1-mediated repression could contribute to the control of ERVs and 
that KAP1 can trigger permanent gene silencing during early embryogenesis, Rowe et al., 
aimed to identify KAP1 target genes and their KRAB zinc finger intermediates. 
Interestingly, they found that KAP1 deletion leads to a marked upregulation of a 
range of ERVs, in particular IAP elements, in mouse embryonic stem cells but also in early 
embryos. Importantly, this was associated with loss of histone 3 lysine 9 trimethylation 
(H3K9me3), a hallmark of KAP1-mediated repression. These results overall demonstrate 
that KAP1 controls endogenous retroviruses in mouse embryonic stem cells (Rowe, Friedli 
et al. 2013).  
4.1.3.6.2.2.CAF-1 
In a recent study from Torres-Padilla lab, authors aimed to identify molecular 
players associated with transitions between pluripotent and totipotent-like states.  
Interestingly, they found that depletion of either the p150 or the p60 subunits of chromatin 
assembly factor-1 (CAF-1) in mouse ES cells increases the population of 2C-like-cells 
which was accompanied by the increased accessibility at MuERV-L, leading to the 
upregulation of neighboring genes. Moreover, they show that induced 2C-like cells after 
CAF-1 depletion display a transcriptional program and the chromatin features of 2-cell-
stage embryos.  
These results along with the higher reprogrammability of CAF-1 depleted ESCs 
through SCNT experiment, overall show that mouse 2C-like cells can be induced in vitro 
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through downregulation of the chromatin-assembly activity of CAF-1. (Ishiuchi, Enriquez-
Gasca et al. 2015) 
4.1.3.6.2.3.KDM1A 
In a similar attempt, the elevation of MuERV-L and 2C-specific genes in KDM1A 
mutant ES is well documented. KDM1A (LSD1) is the first lysine-specific demethylase 1 
that is identified, which demethylates histone H3 mono- and dimethyl K4 and H3K9 and 
depending on the affected histone residue, it either boosts or suppresses gene expression. 
Genome-wide epigenomic profiling of KDM1A mutant ESC demonstrated that in the 
absence of KDM1A, in MuERV-L and a set of 2C- specific genes some chromatin 
modifications occur that favors the derepression of the chromatin, including hyper-
methylation of histone H3K4, hyper-acetylation of H3K27, and hypo-methylation of H3K9 
suggesting that KDM1A is crucial for repressing the expression of genes during early 
phases of embryo development (Macfarlan, Gifford et al. 2011). 
4.1.3.6.2.4. TET family 
Ten- eleven translocation (Tet) family protein are known to be involved in the 
active DNA demethylation through oxidizing 5mC to 5-hydroxymethylcytosine (5hmC) 
(Tahiliani et al. 2009; Ito et al. 2010), which in turn can be further oxidized to 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC) followed by base excision repair to 
complete the demethylation cycle (He, Li et al. 2011, Ito, Shen et al. 2011, Shen, Wu et al. 
2013). 
As the functional characterization of Tet proteins has been complicated by the 
redundancy between the three family members, Lu and Liu et al., generated mouse 
embryonic stem cells (ESCs) deficient for all three Tet proteins (Tet triple knockout 
[TKO]) using CRISPR/Cas9 technology. Importantly they reported a similar 
transcriptional feature of 2C-like state in Tet TKO ESCs. Furthermore, they found that Tet 
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TKO ESCs exhibited increased telomere-sister chromatid exchange and elongated 
telomeres in line with previous report highlighting a remarkable feature of 2C-like cells in 
extending their telomeres (Lu, Liu et al. 2014).  
 
4.1.3.7.Application 
Although the direct reprogramming of differentiated cells to bona fide totipotent 
(like) state is yet too far, uncovering how 2C-like genes are reactivated can give insights 
on the physiology of early embryonic development and may give some clue to make this 
process of reprogramming to totipotent cells feasible. Here I summarize the potential 
applications of 2C-like cells.  
 
4.1.3.7.1. Disease modeling for diseases develop at the primitive stage of embryonic 
development 
As previously mentioned, one of the key applications of iPSC is disease modeling, 
however, iPSC cannot model disease which could initiate at much primitive stages of 
development (prior to blastocyst formation). For example, totipotent-like cells could be an 
ideal recourse for large group of disease known as placenta disease. 
   
4.1.3.7.2. Study of early stages of embryonic development 
One of the main reasons why our knowledge about the physiology and unique 
mechanisms activated at early embryonic stage is limited is due to the fact that we do not 
have faithful in-vitro model which can recapitulate these stages. Thus, totipotent stem cell 
could be instrumental to study the physiology and molecular mechanism underlying these 
early stages. 
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4.1.3.7.3. Improving genomic stability of PSC 
It is known that iPS cells are prone to gain genomic instability during the 
reprogramming process but also over the several steps of propagation in culture. This 
could dramatically hinder their application in disease modeling and regenerative medicine 
(Grskovic, Javaherian et al. 2011). As discussed previously, one of the mechanism that 
PSC could exploit in culture to tackle this problem is through undergoing metastable stage 
to activate totipotency genes, which are proficient in repairing damaged DNA. It is shown 
that not only down-regulation of these genes leads to genomic instability and karyotype 
abnormalities of ESC but more importantly their transient over-expression could lead to 
telomere elongation (Zalzman, Falco et al. 2010) Overall, these findings demonstrate that 
the totipotent cells are more proficient in DNA repair mechanisms and that the transient 
conversion to totipotent state could be beneficial to improve the genomic stability of PSC. 
Thus, understanding how DNA is repaired at the early stages of mammalian embryonic 
development could be of great importance.  
 
4.1.3.7.4. Higher efficiency of reprogramming 
Somatic cell nuclear transfer (SCNT) is a method to generate a viable embryo 
during which a donor nucleus from a somatic cell is implanted in enucleated oocyte. SCNT 
is used in both therapeutic and reproductive cloning, for examples, Dolly the Sheep 
became famous for being the first successful case of the reproductive cloning of a 
mammal. "Therapeutic cloning" refers to the potential use of SCNT in regenerative 
medicine as this approach has been championed as an answer to the many issues 
concerning embryonic stem cells (ESC) and the destruction of viable embryos for medical 
use. One of the main limitations of SCNT is that it is incredibly inefficient (Wilmut, 
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Schnieke et al. 1997). Interestingly, recent papers show that totipotent-like cells have much 
higher capacity for SCNT rather than pluripotent stem cell thus conversion to totipotent 
state could be considered as an alternative way to improve the efficiency of SCNT 
(Ishiuchi, Enriquez-Gasca et al. 2015). Furthermore, 2C-like specific genes could be 
utilized for increasing the efficiency of somatic cell reprogramming as it has been shown 
that by overexpression of Zscan4 the efficiency of reprograming has increased 
significantly (Hirata, Amano et al. 2012). 
 
4.2. DNA replication and replication stress 
4.2.1. Cell Cycle  
Cell cycle is the cellular life cycle that through sequential series of events cell 
regulates its precise DNA replication and cell division. The cell cycle of eukaryotic cells 
consists of four discrete phases namely G1, S, G2 and M phase. Genomic DNA is 
replicated during specific synthesis phase (S) of the cell cycle, which is distinctly separated 
by gap-phase two (G2) from mitosis (M) where segregation of duplicated DNA to daughter 
cells occurs. Mitosis is followed by cytokinesis that splits the cytoplasm between to newly 
generated daughter cells. Two gap phases between M-phase and S-phase (namely G1) and 
between S-phase and mitosis (i.e., G2) are essential not only for duplication of the required 
components of the cell, but also to ensure that the conditions are favorable for accurate 
DNA replication in each cycle through series of checkpoints (Hartwell and Weinert 1989). 
 
4.2.2. Eukaryotic DNA replication  
DNA replication is a semi-conservative mechanism to preserve the genome through 
accurate duplication of DNA strictly once during each cell cycle. In eukaryotes, DNA    
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replication starts in parallel from several predefined sequences so-called replication origins 
that are spread across the whole genome. During the late M transition to early G1 phase of 
the cell cycle, origin recognition protein (ORC) recognizes the origins, and then Cdt1 and 
Cdc6 bind to ORC to create pre-replicative complex (preRC) that is essential for the 
helicase (MCM2-7 complex) loading onto DNA (This step is referred to replication 
licensing). In the next step (G1-S transition), the key replication initiation proteins such as 
Cdc45 and GINS complex are recruited to the DNA through the activation of cycline 
dependent kinase (CDK) and Dbf4 dependent Cdc7 kinases in order to activate replication 
fork and trigger DNA replication initiation. Of note, only a subset of licensed origins are 
activated in each cell cycle while others remain dormant (Yekezare, Gomez-Gonzalez et 
al. 2013) Firing of inactive (dormant) origins plays an essential role in maintaining the 
integrity of the genome in case of fork stalling and replication stress (Yekezare, Gomez-
Gonzalez et al. 2013). Therefore, the organized control of origin firing is fundamental for a 
single round of accurate and timely replication of the genome in each cell cycle (Masai, 
Matsumoto et al. 2010). Upon firing of licensed origins, DNA replication proteins 
construct a fork shape structure, called replication fork (RF) where key replication factors 
coordinate the replication progress. Briefly, helicase activity of MCM complex unwinds 
the DNA duplex; and RPA protein stabilizes the generated ssDNA, follwing which the 
replication elongation takes place via DNA polymerases (pol ε and pol δ) on leading and 
lagging strands of the DNA, respectively (Langston, Indiani et al. 2009, Masai, Matsumoto 
et al. 2010). 
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4.2.3. DNA damage response (DDR) 
Maintenance of the DNA integrity is of paramount value to guarantee the 
protection of genetic information in all living organisms. Thus, to encounter several kinds 
of genotoxic stress that organisms are exposed to, particular mechanisms have been 
evolved. Depending on the type of the DNA damage, DDR pathways is determined by 
activation of different members of PI3K‑like kinases (PIKKs) family, i.e. ataxia-
telangiectasia mutated (ATM), ataxia-telangiectasia and Rad3‑related (ATR) and DNA-
dependent protein kinase catalytic subunit (DNA-PKcs) (Sulli, Di Micco et al. 2012).  
ATM is mainly activated in response to double strand breaks (DSB), while ATR is 
mostly involved in detection of ssDNA. Both kinases phosphorylate the histone variant 
H2AX on Ser139 (γH2AX) in the close region to the DNA lesion. Eventually, ATM and 
ATR in turn phosphorylate Chk2 and Chk1 kinases, respectively, in order to diffuse the 
signal and subsequently activate downstream effector (P53 and cell division cycle 25 
(CDC25)). Activation of effectors end up in various consequences including transient cell 
cycle arrest and restarting of proliferation after DNA repair, programmed cell death 
(apoptosis) or senescence (Sulli, Di Micco et al. 2012). Interestingly, several studies have 
shown that DNA damage in ESC and adult stem cells induce differentiation as an 
alternative outcome of DDR activation (Lin, Chao et al. 2005, Tichy and Stambrook 2008, 
Tichy, Pillai et al. 2010, Serrano, Liang et al. 2011, Schneider, Pellegatta et al. 2013, 
Santos, Faryabi et al. 2014). 
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Fig 1.9.  DNA damage response.  
DDR pathway is composed of two main DNA damage sensors: the MRE11–RAD50–
NBS1 (MRN) complex that detects DNA double-strand breaks (DSBs); and replication 
protein A (RPA) and the RAD9–RAD1–HUS1 complex that detects exposed regions of 
single-stranded DNA. These sensors recruit the apical kinases ATM (through the MRN 
complex) ATR (through RPA and the 9-1-1 complex, which is bound by ATR-interacting 
protein (ATRIP). These in turn phosphorylate (P) the histone variant H2AX on Ser139 
(known as γH2AX) in the region proximal to the DNA lesion. Eventually, DDR signaling 
spreads away from the damaged locus owing to the engagement of diffusible kinases 
CHK2 (which is mainly phosphorylated by ATM) and CHK1 (which is mainly 
phosphorylated by ATR). DDR-mediated cellular outcomes may be cell death by 
apoptosis; transient cell cycle arrest followed by repair of DNA damage and resumption of 
proliferation; or cellular senescence caused by the persistence of unrepaired DNA damage. 
Adapted from (Sulli, Di Micco et al. 2012). 
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4.2.4. Replication stress (RS)  
Although there is no single universally-accepted definition for replication stress, 
usually slowing down the DNA synthesis or stalling of replication fork progression is 
referred as “replication stress” that usually occurs when helicase continue to unwind the 
parental DNA even after polymerase stalling and results in formation of the aberrant fork 
structures with single-stranded DNA (ssDNA) stretches (Pacek and Walter 2004, 
Magdalou, Lopez et al. 2014, Zeman and Cimprich 2014). 
 
4.2.4.1.Sources of replication stress 
Many intrinsic and extrinsic obstacles may challenge the appropriate completion of 
DNA replication, which can cause replication stress. Nicks and stretches of ssDNA, 
barriers for replicative helicase or polymerase, unrepaired DNA lesions, collisions between 
replication and transcription machinery, constitutive activation of oncogenes and physical 
barriers on the chromatin such as secondary DNA structures or DNA-protein complexes 
are some of the possible factors which could trigger replication stress. (Magdalou, Lopez et 
al. 2014, Zeman and Cimprich 2014). Moreover, aphidicolin “a specific inhibitor of DNA 
polymerase ε and DNA polymerase δ “ is a widely used treatment, which disrupts correct 
DNA replication and induces replication stress (Krokan, Wist et al. 1981, Baranovskiy, 
Babayeva et al. 2014). 
 
4.2.4.1.1. Altered origin firing activity 
 Altered origin firing activity is another important factor, which can induce 
replication stress. For instance, over-licensing of origins (firing too many origins) may 
deplete the dNTP pool and slow down the fork progression. On the other hand, firing too 
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few origins can lead to replication stress as well, since it makes it difficult for the 
replication forks to travel long distances on the genome and it causes under-replication 
which leads to loss of genetic information in particular in regions that are hard to be 
replicated such as heterochromatins . (Letessier, Millot et al. 2011, Magdalou, Lopez et al. 
2014, Zeman and Cimprich 2014). In addition, it has been shown that Cdc45, a key factor 
required for replication initiation, is rate limiting for origin firing in mammalian cells since 
it is present at much lower concentration with respect to other replication factors 
suggesting that the overexpression of Cdc45 could activate dormant origins and increase 
the overall replication rate (Wong, Winter et al. 2011). Besides, it has been proved that, 
similar to c-Myc, in Xenopus, Cdc45 overexpression induces replication stress by firing 
too many origins that subsequently leads to DNA damage (Srinivasan, Dominguez-Sola et 
al. 2013). 
 
4.2.4.1.2. Limited source of nucleotides 
The amount of nucleotides needs to be well-balanced for the successful 
accomplishment of replication process as deregulation of nucleotide pool may result in 
replication stress, mutagenesis and genomic instability. In over-activated origins, 
replication stress is induced due to quick exhaustion of the existing dNTP pool. Moreover, 
hydroxyurea (HU), which inhibits ribonucleotide reductase enzyme, depletes nucleotide 
storage of the cells and induces replication stress suggesting that supplying the additional 
amount of nucleotides through exogenous sources may rescue the fork stalling and 
replication stress (Young and Hodas 1964, Poli, Tsaponina et al. 2012). 
 
4.2.4.2.Replication stress response 
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As it is mentioned above, replication stress mainly take place due to the helicase-
polymerase uncoupling, accompanied by accumulation of ssDNA in the close district to 
stalled replication fork and progressed by the recruitment of replication protein A (RPA) to 
ssDNA. It has been well-documented that RPA-coated ssDNA serves as a signaling 
platform for mediating replication stress response and recruiting the key replication stress-
proteins such as ataxia-telangiectasia mutated (ATM)- and Rad3-related (ATR) kinases. 
(Pacek and Walter 2004, Byun, Pacek et al. 2005, Zeman and Cimprich 2014). Activation 
of ATR as the “central replication-stress-response kinase” phosphorylates its substrates to 
help cells to complete their accurate replication in stressing conditions. Phosphorylation of 
the histone variant H2AX (γH2AX) is one of the most commonly used markers to detect 
replication stress. However, since γH2AX can be detected in different types of DNA 
damage, it is not a specific replication stress marker. Though, phosphorylation of RPA (on 
Ser 33) or CHK1 (on Ser 345), detection of ssDNA directly or indirectly through native 
BrdU immunofluorescence or RPA foci formation, measurement of DNA synthesis 
progress through DNA combing assay, detection of higher levels of ssDNA gaps and 
detecting reversed forks through electron microscopy approach could more specifically 
reflect ATR dependent replication stress (Zou and Elledge 2003, MacDougall, Byun et al. 
2007, Nam and Cortez 2011, Bianco, Poli et al. 2012, Marechal and Zou 2013, Ahuja, 
Jodkowska et al. 2016). 
Upon replication stress, ATR helps to stabilize and restart the stalled fork after the 
source of replication stress has been removed. However, if the source cannot be banned, 
two other mechanisms prevent prolongation of fork stalling and restart the replication fork. 
The first mechanism is firing close by dormant origins (Yekezare, Gomez-Gonzalez et al. 
2013) and the second one is continuing the replication downstream of the stalled fork by 
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leaving the un-replicated ssDNA gap close to the lesion in order to be replicated later 
through compensatory mechanisms such as DNA damage tolerance pathway (DTT). For 
example, cells can bear the presence of un-replicated ssDNA gaps during replication 
through utilizing specialized polymerases or sister chromatid as a template (Lopes, Foiani 
et al. 2006, Petermann and Helleday 2010, Elvers, Johansson et al. 2011, Mailand, Gibbs-
Seymour et al. 2013). 
Nevertheless, in spite of such complex mechanisms that cells exploit to keep the 
stalled fork stable, replication forks could collapse or become inactive as a result of 
persistent replication stressing source or loss of ATR response pathway components which 
in turn lead to double strand break (DSB) formation and activation of other DNA damage 
response markers i.e. ATM and DNA-PK. (Lopes, Cotta-Ramusino et al. 2001, Tercero 
and Diffley 2001, Chanoux, Yin et al. 2009) (Ciccia and Elledge 2010).  
 
4.2.4.3.Replication stress and human diseases 
Several human diseases are directly associated with deficiencies in the replication 
stress response pathways. Fork collapse, deficient DNA replication and deregulation of 
transcription or other processes linked to DNA replication and the way cells cope with 
stresses, all together could potentially contribute to DNA damage, mutations and 
eventually diseases. Depending on the proteins and replication stress signaling pathways 
that are defected, there are huge varieties in disease phenotypes. The name and associated 
phenotype of each disease plus affected DNA response proteins are listed precisely in 
(Zeman and Cimprich 2014) review. 
 
4.2.4.4. ATR Seckel syndrome 
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ATR is the central kinase to be activated during replication stress and its total loss 
is shown to be embryonic lethal. Furthermore, drop in ATR protein expression in human 
patients and animals with a hypomorphic allele of ATR or a mutation in ATR-Interacting 
Protein (ATRIP) that is required for ATR stability and recruitment to the site of damage, 
results in a severe syndrome called Seckel syndrome. These patients suffer from 
microcephaly, developmental delay and mental retardation.  
It has been demonstrated that conditional knock down of ATR is sufficient to 
accelerate premature aging related phenotypes (Ruzankina, Pinzon-Guzman et al. 2007). A 
mouse model of Seckel syndrome has been generated by Fernandez-Capetillo group in 
2009 by swapping the mouse ATR allele with the human counterpart and introducing the 
Seckel mutation from A to G in exone 9. This mutation promotes the skipping of exone 9 
during splicing and results in severe ATR hypomorphism. Interestingly, Capetillo group 
reported high levels of replicative stress in ATR Seckel mice mostly during 
embryogenesis, when proliferation is widespread. However, replicating stress was reduced 
to marginal amounts in postnatal life. Moreover, adult Seckel mice showed accelerated 
aging recapitulating of Seckel syndrome despite of decrease in replication stress in 
postnatal life. Altogether, these results suggest that replicative stress, particularly in utero, 
could contribute to the onset of aging in postnatal life (O'Driscoll and Jeggo 2008, Murga, 
Bunting et al. 2009, Ogi, Walker et al. 2012, Zeman and Cimprich 2014). 
 
A	 B	 C	
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Fig 1.10. Strategy for generating the mutant ATR allele.  
A) The rearranged allele contains the genomic region encompassing human exons (E) 8–
10 (pink) inserted into the equivalent region of the mouse ATR gene (red exons). The 
Seckel syndrome mutation is indicated in E9. B) Analysis of littermate MEF lines by PCR 
genotyping (RT-PCR of ATR with primers at E8 and E10). C) Representative pictures of 
ATR+/+ and ATRS/S mice at 3 months of age. Modified from (Murga, Bunting et al. 
2009)  
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4.3. Cell cycle and DNA damage response in ESC  
4.3.1. Cell cycle profile of pluripotent cells 
Mouse ESC have a particular and rapid cell cycle profile which takes about 10-12 
hours with respect to somatic cells in which the cell cycle length is more than 24 hrs. 
(Stead, White et al. 2002) 
The unique cell cycle profile of ESC features a high proportion of cells in S-phase 
(60-70%) and very short G1 phase with a smaller proportion of cells (15-20%) in 
comparison to somatic cells that spend most of their time (more than 70%) in gap phases 
and less time in S-phase (about 20%). Nevertheless, the lengths of the S-phase and M 
phase in pluripotent cells are comparable to somatic ones (White and Dalton 2005, Li, 
Ballabeni et al. 2012, Suvorova, Katolikova et al. 2012).  
Furthermore, ESC not only have much higher amount of cell cycle regulatory 
factors such as Cdc6, Cdc25a and cyclins in comparison to MEFs, but also, most of these 
regulatory factors in particular the ones monitoring the proper origin licensing, remain 
constant. This is in contrast to somatic cells where such regulatory elements are oscillating 
(degraded and resynthesized) during each cell cycle (Tichy, Pillai et al. 2012).  
Of note, ESC have a compromised G1-S checkpoint (cell cycle arrest) following 
DNA damage, which is considered as a safeguard mechanism to prevent differentiation, 
since it has been shown that in G1 phase, MEK signaling pathway regulates the 
transcription of genes responsible for induction of early differentiation. Moreover, the 
suppression of MEK pathways negatively regulates the proliferation of somatic cells; while 
it doesn’t affect ESC growth and even contributes to keep ESC undifferentiated. (Ying, 
Wray et al. 2008, Suvorova, Katolikova et al. 2012). 
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Above-mentioned remarks, could explain the higher proliferation rate in pluripotent 
cells and their peculiar cell cycle profile which is needed to maintain their self-renewal and 
pluripotency features (Suvorova, Katolikova et al. 2012, Tichy, Pillai et al. 2012).  
 
4.3.2. DNA damage response in ESC 
A robust and efficient DNA damage response is of paramount importance for ESC, 
mostly since any defect in the genome of these cells could be inherited to all cell types of 
three embryonic lineages. Moreover, given the high proliferative capacity and the unique 
cell cycle profile of these cells (including G1-S checkpoint deficiency), the accurate and 
constitutively active DDR and maintenance of genome integrity is even more critical in 
ESC (Suvorova, Katolikova et al. 2012).  
Several studies have reported that, mESC have much lower frequency of 
undesirable mutations with respect to differentiated cells such as MEF cells, which 
underlines the fact that ESC get rid of damaged cells either through apoptosis as mESC are 
hypersensitive to damaging agents, or through highly efficient DNA repair mechanisms. 
Of note, it has been proved by several groups that mouse ESC predominantly exploit the 
high fidelity homologous recombination repair (HRR) mechanism to repair their damaged 
DNA, however differentiated cells mostly use error-prone non homologous end joining 
(NHEJ) mechanism showing that mESC are inherently different from differentiated 
somatic cells in terms of their great capacity to repair DNA damage to ensure the genome 
integrity during early development. Of note, some evidences suggest that treatment with 
damaging agents may cause premature differentiation of ESC in P53 dependent manner as 
an alternative way to sustain their genomic stability. (Lin, Chao et al. 2005, Tichy and 
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Stambrook 2008, Tichy, Pillai et al. 2010, Serrano, Liang et al. 2011, Schneider, Pellegatta 
et al. 2013, Santos, Faryabi et al. 2014) 
It has been demonstrated that the key DNA damage activated kinases (i.e., ATM 
and ATR) are involved in DDR of ESC. Although ATR and ATM activation is mainly 
linked to replication stress and DSB, respectively, several evidences proved that ATR 
activation could also take place upon DSB in ATM dependent manner (Myers and Cortez 
2006).  
As previously mentioned, ATR knockout is found to be embryonic lethal which 
could be justified due to very high proliferation rate of ESC which expose them to DNA 
replication stress (Murga, Bunting et al. 2009). In contrast, ATM knockout mice are born 
live and could repair DSB in error prone manner (Banuelos, Banath et al. 2008).  
  
4.3.3. High level of γH2AX in mESC is linked to constitutive replication stress 
It has been shown previously that both in vivo and artificially derived PSC 
accommodate high amount of γH2AX even in the absence of DNA damaging agents. 
However, since high level of γH2AX couldn’t be linked to DSB formation (due to the 
absence of co-localization with DSB specific markers such as ATM or 53BP1), the reason 
for its high phosphorylation was unclear and attributed to specific and undefined PSC 
chromatin features (Chuykin, Lianguzova et al. 2008, Banath, Banuelos et al. 2009, 
Ziegler-Birling, Helmrich et al. 2009, Turinetto, Orlando et al. 2012). 
Recently, it has been revealed that, phosphorylation of H2AX is directly associated 
with ATR activation and accumulation of ssDNA during fast replication rounds of ESC, 
mostly due to their fast G-S transition (Ahuja, Jodkowska et al. 2016). Furthermore, it has 
been proved that, delaying G1-S transition by Cdc7 inhibitor (which interrupts origin 
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firing) leads to longer G1 phase in ESC and less amount of γH2AX and replication stress 
in the following S-phase. This suggests replication-coupled mechanisms that are needed to 
keep the self-renewal property and genome integrity of ESC (Chuykin, Lianguzova et al. 
2008, Ahuja, Jodkowska et al. 2016).  
 
 
 
 
 
 
 
Fig 1.11. Model depicting differential control of genome stability in ESCs and 
proliferating somatic cells. 
Under-replicated regions and residual DNA damage are unavoidably present at the end of 
each S-phase in both ESCs and somatic cells. However, owing to the brief gap phases, 
ESCs channel a high number of these lesions in the following S-phase and protect genome 
integrity by extensive fork reversal and replication-coupled repair. Conversely, 
differentiated cells have prolonged gap phases, assemble 53BP1 NBs and repair most of 
these lesions before S-phase entry. Adapted from (Ahuja, Jodkowska et al. 2016). 
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5. Materials 
 
Reagents and medium components: 
High glucose DMEM media - GlutaMAX™-I, Gibco, Life technologies 32430-100 
High glucose DMEM, Lonza BE12-614F 
RPMI (1640), Lonza BE12-167F 
ESC qualified FBS HyClone™ Fetal Bovine Serum (SH30070.03) 
Leukemia inhibitory factor (LIF), home made 
MEM-Non essential amino acids 100x, Microtech X0557 
Fetal Bovine Serum (FBS), North American, Sigma Aldrich F2442 
Fetal Bovine Serum, South American, Biowest-S1810-500 
Sodium Pyrovate 100mM, Microtech L0642 
2-Mercaptoethanol, Life technologies 31350-010 
L-glutamine, Microtech X0550 
Penicillin Streptomycin, Microtech L0022 
Gelatine type A porcine skin, Sigma aldrich G2500-100G 
Doxycycline hydrochloride, Sigma Aldrich D9891-5G 
KnockOut serum replacement (KSR), Life technologies 10828-028 
Leukocyte Alkaline Phosphatase Kit, Sigma Aldrich 86R-1KT 
PD 0325901 (Axon medchem, Axon 1408) 
CHIR 99021 (Axon medchem, Axon 1386) 
RNeasy mini kit (Qiagen, 74104) 
SuperScript TM III reverse transcriptase kit (Invitrogen 18080-093)  
SsoFastTM EvaGreen® Supermix (Bio-rad) 
 
  
 
 
51 
ATMi (KU-55933), Axon 1367 
ATRi (VE 822), Axon 2452  
Chk1i (UCN-01) 
Cdc7i (PHA767491)   
FGF4 (R&D Systems, 235-F4-025)  
Heparin (Sigma, H3149) 
Puromycin, Vinci-adipogen, AG-CN2-0078-M100 
Protease/phosphatase inhibitor cocktail (cell signalling, 5872)  
pLVX-EF1α-IRES-Puro vector (Clontech 631988) 
pLVX-EF1α-IRES-mCherry cevtor (Clontech 631987) 
 
List of Antibodies: 
Alexa Fluor® 647 anti-H2AX- Phosphorylated (Ser139) antibody (Biolegend 613408) 
Anti Oct-3/4 antibody (Sanra Cruz, sc-5279) 
Anti Nanog (Abcam, ab80892) 
Anti SSEA1 (Millipore, MAB4301C3) 
Anti 53BP1 (Bethyl laboratories, A300-272) 
Anti γH2AX (Millipore, 05-636) 
ATR antibody (Cell Signalling, 2790) 
Cdc6 antibody (Santa Cruz, sc-9964) 
Cdc45 antibody (Santa Cruz, sc-20685) 
Phoshpho-Chk1 antibody -S345 (Cell signaling 2348) 
Total Chk1 antibody (Santa cruz 8408) 
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6. Methods 
 
6.1. Cell culture 
ESCs were grown in feeder free culture condition either with or without 0.1% gelatin 
coat and incubated in 37°C and 3% O2 tension. ESC medium (high glucose DMEM 
(DMEM Media - GlutaMAX™-I, Gibco)), 15% ESC qualified FBS (HyClone™ Fetal 
Bovine Serum), 2 mM L-glutamine, 1/500 home-made leukemia inhibitory factor, 0,1 mM 
non-essential amino acids, 0,1 mM 2-bmercaptoethanol, 50 units/ml penicillin, 50 mg/ml 
streptomycin, 1mM Sodium Pyruvate) supplemented with two inhibitors (2i from Axon 
medchem) that are PD 0325901; highly specific non-ATP-competitive inhibitor of MEK 
(aka MKK) 1/2 at final concentration of 1uM and CHIR 99021; specific glycogen synthase 
kinase GSK-3 inhibitor at final concentration. MEF cells were cultured in MEF medium 
(high glucose DMEM (Lonza), 10% north America FBS, 2 mM L-glutamine, 0,1 mM non-
essential amino acids, 50 units/ml penicillin, 1mM Sodium Pyruvate and 50 mg/ml 
streptomycin). 
 
6.2. Treatments 
All treatments including APH, HU, UV, ATRi, ATMi, Cdc7i, Chk1i were added in to 
fresh ESC medium and the cells were kept in 37°C and 3% O2 tension for overnight (16-17 
hrs) unless mentioned in each particular result section. APH was used at various 
concentrations ranging from 0.3uM to 6uM that is mentioned in each experiment in order 
to induce mild or acute replication stress response. Similarly, HU was used at 0.1mM-
3mM. ATMi (KU-55933) and ATRi (VE 822) were used at the concentration of 10uM and 
1uM respectively. Moreover, Chk1i (UCN-01) at the concentration of 100nM and Cdc7i 
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(PHA767491) at the concentration of 5uM were used. UV radiation was performed at the 
dosage ranging from 2 to10 J/m2. 
 
6.3. Flow cytometry (FACS) 
Zscan4-Emerald ESCs were fixed and permeabilized using Cytoperm/Cytofix kit (BD 
Biosciences), and subsequently stained for one hour at room temperature with Alexa 
Fluor® 647 anti-H2AX- Phosphorylated (Ser139) antibody (Biolegend). Cells were 
washed and acquired on a FACS Calibur instrument. For Caspase3 FACS analysis after 
fixation and permeabilization, Caspase3 antibody were used for one hr at RT followed by 
washes and one hr incubation in donkey anti rabbit secondary antibody. For Zscan4-
Emerald-GFP acquisition cells were trypsinized, collected and subsequently acquired 
without fixation step.  
 
6.4.  RNA extraction, cDNA synthesis and qPCR 
RNA was extracted using RNeasy mini kit (QIAGEN), quantified by NanoDrop 
spectrophotometer and cDNA was prepared from 2 µg total DNA-depleted RNA using 
SuperScript TM III reverse transcriptase kit (Invitrogen cat# 18080-093) following 
manufacturer’s instructions. qPCR assay performed based on standard protocol using 10X 
SsoFastTM EvaGreen® Supermix, 10 µM primer mix and a total amount of cDNA 
corresponding to 5 ng of starting RNA for each reaction. For the list of oligos used in this 
study please refer to (Takahashi and Yamanaka 2006, Macfarlan, Gifford et al. 2012). 
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6.5. Immunocytochemistry 
Briefly cells fixed in 4% PFA and subsequently blocked for one hour in FBS (10%) 
and Triton (0.1%). Then, cells were incubated with primary antibody at 4°C overnight, 
followed by washes and incubation with secondary antibody for an hour at room 
temperature. Next samples were mounted and images were acquired with wide field 
florescent microscope. Antibodies used in this study were Anti Oct-3/4 (Sanra Cruz sc-
5279), Anti Nanog (Abcam ab80892), Anti SSEA1 (Millipore MAB4301C3), Anti 53BP1 
(Bethyl laboratories #A300-272), Anti γH2AX (Millipore 05-636). Acquired figures were 
analyzed with ImageJ software. 
 
6.6. Immunoblotting 
The cells were trypsinized and washed with PBS and then lysed in RIPA buffer plus 
protease/phosphatase inhibitor cocktail (cell signalling, #5872), incubating for 30 minutes 
on a rotating wheel at +4°C. Lysates were sonicated with a Bioruptor Sonication System 
(UCD200) at high power for 3 cycles of 30 seconds with one minute breaks. Lysates were 
centrifuged at 13000 rpm for 20-30 minutes and clear supernatants were transferred to new 
tubes. The proteins were quantified using Bio-Rad protein assay and following 
manufacturer's instructions. For the detection of each protein, 35 µg of total protein 
extracts were loaded. Standard western blot was performed using following antibodies: 
ATR antibody (Cell Signalling 2790), Phoshpho-Chk1 antibody -S345 (Cell signaling 
2348) Cdc6 antibody (Santa Cruz sc-9964), and Cdc45 antibody (Santa Cruz sc-20685).  
 
6.7. Target preparation for microarray 
The quality of total RNA was first assessed using an Agilent Bioanalyzer 2100 
(Agilent Technologies, Palo Alto, CA). Biotin-labeled cDNA targets were synthesized 
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starting from 150 ng of total RNA. Double stranded cDNA synthesis and related cRNA 
was performed with GeneChip® WT Plus Kit (Affymetrix, Santa Clara, CA). With the 
same kit was synthesized the sense strand cDNA before to be fragmented and labeled. All 
steps of the labeling protocol were performed as suggested by Affymetrix. Each eukaryotic 
GeneChip® probe array contains probe sets for several B. subtilis genes that are absent in 
the samples analyzed (lys, phe, thr, and dap). This Poly-A RNA Control Kit contains in 
vitro synthesized, polyadenylated transcripts for these B. subtilis genes that are pre-mixed 
at staggered concentrations to allow GeneChip® probe array users to assess the overall 
success of the assay. Poly-A RNA Controls final concentration in each target are lys 
1:100,000, phe 1:50,000, thr 1:25,000 and dap 1:6,667. 
 
6.8. DNA Strip hybridization 
Hybridization was performed using the GeneAtlas™ Hybridization, Wash and Stain 
Kit. It contains a mix for target dilution, DMSO at a final concentration of 10% and pre-
mixed biotin-labeled control oligo B2 and bioB, bioC, bioD and Cre controls (Affymetrix 
cat# 900299) at a final concentration of 50 pM, 1.5 pM, 5 pM, 25 pM and 100 pM 
respectively. Targets were diluted in hybridization buffer at a concentration of 0.05 µg/ul, 
denatured at 99 °C for 5 minutes, incubated at 45 °C for 5 minutes and centrifuged at 5,000 
rpm for 1 minute. The Array Strip is then moved to a hybridization tray, which contains 
the hybridization cocktails. A single Gene 2.1 PEG Array Strip is hybridized with four 
different biotin-labeled targets. Hybridizations were performed for 20 hours at 48°C in the 
GeneAtlas™ Hybridization Station. The Array Strips were washed and stained in the 
GeneAtlas™ Personal Fluidics Station. At the end of this procedure the array strips were 
placed into the imaging tray, which contains the Array Holding buffer. 
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6.9. Image acquisition, processing and bioinformatics analysis 
The array strips were imaged using the GeneAtlas™ Imaging Station. Affymetrix 
GeneAtlas™ Command Console software was used to acquire the Array Strip images and 
generate. 
Differential expression analysis 
We imported the microarray CEL files into R-3.2.2 (R Core Team. 2015. R: A 
Language and Environment for Statistical Computing. https://www.r-project.org/ 
(Accessed September 12, 2016) and normalized intensity values with RMA (Irizarry, 
Hobbs et al. 2003) normalization. We performed differential expression analysis using the 
limma (Ritchie, Phipson et al. 2015) package, weighting arrays with the arrayWeights 
function (Ritchie, Diyagama et al. 2006) and calculating p-values with an empirical Bayes 
method (Smyth 2004). 
Expression Z-scores were calculated using the probe set level RMA normalized microarray 
intensity values using the standard formula: 𝑍 − 𝑠𝑐𝑜𝑟𝑒 = 𝑥 −  µ𝜎  
Where 𝑥 is the RMA normalized microarray intensity, µ is the probeset level average 
intensity value across all samples, and σ is the probeset level standard deviation of the 
intensity values. 
Gene set enrichment 
The CAMERA gene set enrichment p-values were calculated using the limma 
package and the camera function (Wu and Smyth 2012). Gene sets were defined based on 
the MsigDB gene sets (Subramanian, Tamayo et al. 2005), using a mouse orthologous 
collection (Hu Y. 2016. Mouse and human orthologues of the MSigDB in R format. 
http://bioinf.wehi.edu.au/software/MSigDB/ (Accessed September 12, 2016). 
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In the GSVA based enrichment analysis, we used the MsigDB gene sets, and transformed 
the individual gene expression values into gene set expression values with the GSVA 
package (Hanzelmann, Castelo et al. 2013). We calculated the gene set differential 
expression as in the gene level differential expression analysis, only skipping the RMA 
normalization step. 
 
6.10. Genotyping of ATR Seckel ESC 
In order to obtain homozygous ATR Seckel ESC, all nine ESC lines derived from 
breeding of ATR Seckel heterozygous mice were genotyped using previously 
described primer sets (Murga, Bunting et al. 2009). 300bp and 545 bp bands 
correspond to WT and ATR Seckel -/- genotypes. 
 
6.11. In-vitro differentiation toward giant trophoblast-like cells 
ATR Seckel and WT ESCs were seeded on gelatin coated 6-well plate in ESC medium 
and 24 hours post treatment, medium was changed to trophectoderm stem cell (TSC) 
differentiation medium, which contains: 30% RPMI 1640 (with 20% FBS, 1mM pyruvate, 
2mM L-glutamine, 100 mM β-mercaptoethanol), 70% of conditioned medium from 
mitomycin-C-inactivated fibroblasts, 25 ng/ml of FGF4 (R&D Systems, 235-F4-025) and 
1 ug/ml of heparin (Sigma, H3149). We changed the medium with fresh one every other 
day to maintain TSCs. To induce giant cell differentiation established TSC were split at 
day 2 on gelatin coated plate. After 24 hrs medium was changed to RPMI 1640 (with 20% 
FBS, 1mMpyruvate, 2mML-glutamine, 100 mM β-mercaptoethanol) in the absence of 
heparin and FGF4, therefore, we changed the medium every other day for 3 days. 
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6.12. Mouse chimaera assay 
Briefly, morula stage embryos were bought from Charles River laboratories. They were 
thawed few hours prior to injection and about five to eight ESC were injected into the 
perivitelline space of high quality morula-stage embryos using laser-assisted technique and 
glass micro-capillary tubes. Finally, embryos were cultured for 24 hours at 37C, 5% CO2 
to allow the blastocysts development prior to the microscopic analysis.  
 
6.13. Molecular Cloning 
The sequences corresponding to mouse Cdc45 and Cdc6 cDNA were amplified by 
polymerase chain reaction from Origene Clones (NM_009862 and NM_001025779) using 
the primers below and cloned into the pLVX-EF1α-IRES-Puro (#631988) vector from 
Clontech and were transformed in TOP10 Chemically Competent E. coli (Invitrogen) and 
sequenced for checking the accuracy of the clone sequences. 
1) Mouse-Cdc45-SpeI-Fw: 5’-GACTAGTACCATGTTCGTGACCGATTTCCGCAAG-3’ 
2) Mouse-Cdc45-FLAG-BamHI-R: 
 5’-
CGCGGATCCTCACTTGTCATCGTCGTCCTTGTAGTCTCCTCCTCCGGACAGCAG
TGACACAAGAG-3’  
3) Mouse-Cdc6-SpeI-Fw: 5’-GACTAGTACCATGCCTCAAACCAGATCCCAGACA-3’   
4) Mouse-Cdc6-HA-BamHI-R:  
5’-
CGCGGATCCTCAAGCGTAATCTGGAACATCGTATGGGTATCCTCCTCCGGGCA
GACCAGCAGCG-3’ 
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6.14. Lentivirus production 
pLVX-EF1α-IRES-mCherry vector was co-transfected with plasmids that are 
expressing POL, REV, TAT, and the vesicular stomatitis virus envelope glycoprotein 
(VSV-G) into 80% confluent 293T cells using calcium phosphate precipitation in the 
presence of 25mM chloroquine. The supernatant of transfected cells were collected every 
24 hrs for two days and concentrated using PEG-itTM virus precipitation solution and viral 
particles were re-suspended in DMEM and frozen in small aliquots in -80. 
 
6.15. Somatic cell reprogramming 
Somatic cell reprogramming was carried out using Dox-inducible polycistronic 
lentiviral vector STEMCCA, which consists all four reprogramming factors Oct4, c-Myc, 
Klf4 and Sox2 (Sommer, Stadtfeld et al. 2009). 105 low passage Oct4-GFP MEFs were 
seeded at clonal density in 6-well plate on day0. On the next day, cells were infected with 
STEMCCA and rtTA viruses in the presence of 8ug/ml polybrene. On day2, infected cells 
were trypsinized, counted and re-plated on mitomysin-inactivated MEF feeder layer. The 
day after MEF medium was replaced with iPSC medium (high glucose DMEM, 15% 
knockout serum replacement-Invitrogen-, 2 mM L-glutamine, 1/500 home-made leukemia 
inhibitory factor, 0,1 mM non-essential amino acids, 0,1 mM 2-bmercaptoethanol, 50 
units/ml penicillin, 50 mg/ml streptomycin) supplemented with 1 ug/ml doxycycline to 
induce expression of the reprogramming factors and medium was changed daily till 
colonies started to emerge. Around day 6 small morphological changes started to appear 
and iPSC colonies emerged after about two weeks of reprogramming induction. On day 20, 
Dox was withdrawn from medium and a week later each bona fide iPSC were picked with 
needle and expanded on a MEF feeder layer to establish individual clones for further 
characterization.  
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6.16. Alkaline phosphatase assay 
Alkaline phosphatase (ALP) is a hydrolase enzyme, which removes phosphate groups 
from various molecules, such as alkaloids and proteins. The undifferentiated and self-
renewing ICM-derived mESC, have a high ALP activity (Johnson, Calarco et al. 1977). To 
test the pluripotency features of iPSC I performed ALP assay using Alkaline Phosphatase 
Detection Kit (Sigma) and acquired the images using an Olympus AX70 wide field 
microscope. 
 
6.17. In-vitro differentiation of PSC toward three embryonic germ layers 
To induce embryoid body formation, four million iPSCs were plated in non-adherent 
bacterial dish in 15 ml EB medium (iPSC medium without LIF plus 10% FBS) for four 
days and the medium was replaced with fresh medium every other day. At day five, EBs 
were re-plated on gelatin-coated adherent dishes for further differentiation and the medium 
was changed every other day for another week. 
 
6.18. Definition of the mathematical model and solution 
 The model describes the dynamics of the number of positive and negative cells. 
Positive cells stochastically duplicate with rate b+, die with rate d+, and switch to negative 
state with rate k+; negative cells duplicate with rate b-, die with rate d-, and switch to 
positive state with rate k-. Mean-field deterministic rate equations for these processes can 
be obtained: 
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(1) 
Here, N+ and N- are the numbers of positive and negative cells respectively, and birth and 
death rates appear only through the combinations 
 
Eq (1) can be solved analytically. The general solution is a complicated expression, which 
we do not quote here. To give an example, by taking the initial condition 
 
 
one gets the following expression for the dynamics of the number of Zscan4 positive cells: 
 
 
Not all combinations of parameters give rise to a mixed long-time state, with non-zero 
fraction of positive and negative cells. In fact, a condition for this to happen is q+ = q-, 
i.e., the equality of the total net growth rates (duplication minus death) for the two cell 
states. 
In this case, the rate equations in Eq. (1) imply a simple closed system of equations for the 
fractions of positive and negative cells, defined as 
 
Specifically, 
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(2) 
Whenever q+ = q-, Eq. (2) shows that the stable fraction of positive cells is 
 
(3) 
Comparison of Model and Data 
 Full solution of Eq (1) shows that, in general, if the net growth rates q+ and q- are 
unbalanced, such long-time stable fraction of treated vs untreated cells is not reached.  
Hence, we suppose that this balance condition is fulfilled for the control experiment, for 
which a stationary mixed population is reached after approximately 4 days. Under this 
condition, Eq. (3) can be used to estimate the combination of model parameters appearing 
in the right-hand side from the long-time values. We estimated errors bars from a standard 
multi-branch fit of the solution to Eq. (2) against data with the two different initial 
conditions (100% and 0% Zscan4-positive cells). This fit gives: 
 
 
We tested; by using the model, whether the experimental data in treated conditions may be 
reproduced in the null scenario where the switching rates k+ and k- are the same as in the 
control. Importantly, the model applies to conditions where the parameters, and in 
particular the switching rates are constant. If the experiment with drug treatment is 
prolonged for multiple days, the drug is diluted (in a way that is not completely 
controlled). Therefore, it makes sense to compare data and model after one day of 
treatment. Any measurement at later times would need to fix unknown time-varying 
parameters in the model, which is unfeasible with the current resolution and statistics of 
the data. 
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Since the drug treatment can affect division and death rates differently, q+ and q- can be 
(and are likely) different in this case. Hence, when comparing the model to the result in the 
treated condition one cannot use the assumption that a stable state is reached by the system 
at long times, other than the trivial one with 100% positive cells.  However, with fixed k+ 
and k-, a relation between q+ and q- must be satisfied in order to reproduce the empirical 
cell counts in the treated cultures from day 0 to day 1. This constraint is imposed using the 
full analytical solution to Eq. (1). 
This operation constrains the model up to only one free parameter (q+). Plotting the 
possible theoretical curves for the time course of the fraction of Zscan4-positive cells by 
varying q+ (Fig. 1) shows that the experimental data at day 1 can be reproduced only if q+ 
is at least a factor f=2.2 larger than it is in the control (considering the effect of the 
uncertainty in the parameters k+ and k-, the fold change factor f lays in the range 1.8 – 
2.7). This would correspond to an extremely unrealistic situation in terms of changes in 
division and death rates determined by the drugs, which could be observable in only one 
day. For example, if the death rate is negligible in the untreated conditions, then, even 
taking the worst case scenario that in the treated conditions the death rate is unaffected, 
treated cells would have to divide 2-3 times per day, which is unrealistic. Hence, this 
analysis supports the conclusion that changes in the switching rates are determined by the 
effect of the drug. 
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7. Results 
Although the extended developmental potential of 2C-like cells in generating 
embryonic plus extra-embryonic tissues as well as their higher reprogrammability through 
SCNT assay has been explored by several groups (Macfarlan, Gifford et al. 2012, Amano, 
Hirata et al. 2013, Ishiuchi, Enriquez-Gasca et al. 2015), the signal triggering reactivation 
of totipotency genes in PSC culture and the exact molecular mechanism underlying the 
reactivation of 2C-like transcriptional signature is not well investigated yet (Fig 7.1). 
Due to the critical role of Zscan4 and some other 2C-like genes expression in 
regulating the genomic stability of PSC and previously reported constitutively active 
replication stress response in mouse embryonic stem cells under normal culture condition 
(Ahuja, Jodkowska et al. 2016), here we asked if the expression of Zscan4 and activation 
of 2C-like genes network are controlled by activation of the DNA damage response 
pathways as a unique characteristic feature of PSC.  
 
Fig 7.1.  The molecular mechanism 
underlying transition to totipotent-
like state is unknown. 
About 1-5% of cells in PSC culture 
express 2C-like specific genes such as 
Zscan4, MuERV-L, Gm4340 and 
Gm12794. 2C-like cells have shown 
higher potency in functional assay, 
however, the exact molecular 
mechanism that regulates transitioning 
to such state is not yet known.  
?
Metastable PSC
Zscan4d,	MuERV,	
GM4340,	GM12794,	
Oct4,	Sox2,	Nanog
2-cell	embryo																																																						Blastocyst
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7.1. ATR mediated DNA damage response triggers activation of key 2C-like specific 
genes in mESC 
It has been shown that transient burst of Zscan4 expression, play a critical role in 
maintaining the genomic stability of ESC (Zalzman, Falco et al. 2010). Moreover, several 
studies have demonstrated that the DNA damage response (DDR) is constitutively active 
in ESC due to high proliferation rate and constitutive replication stress, (Chuykin, 
Lianguzova et al. 2008, Banath, Banuelos et al. 2009, Ziegler-Birling, Helmrich et al. 
2009, Ahuja, Jodkowska et al. 2016). Therefore, we tested whether Zscan4 expression 
level is associated with constitutively active replication stress response in ESC under 
normal culture condition. To test this hypothesis, we first examined the basal level of 
γH2AX as an indicator of DDR activation in Zscan4-Emerald ESC line. Interestingly, flow 
cytometry analysis revealed a significant enrichment of γH2AX positive cells within 
Zscan4-Emerald positive population with respect to Zscan4-Emerald negative ESC 
population (Fig 7.2A). 
Hence, we asked if the expression of the key totipotency specific genes such as 
Zscan4 and MuERV-L is responsive to the further activation of replication stress response 
through extrinsic stimuli. To this end, we exposed Zscan4-emerald ESC to aphidicolin 
(APH) and hydroxyurea (HU), two well-known agents that induce replication stress and 
subjected them to FACS analysis. As shown in Fig.7.2B and C, in APH and HU treated 
conditions, the proportion of Zscan4 positive cells was increased significantly in 
comparison to untreated control (CNT).  
Next, to dissect the contribution of the main apical kinases in reactivation of 2C-
like specific genes in PSC culture, we asked if suppression of DDR pathways could 
restrain the activation of main totipotency genes under normal and DNA damage response 
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inducing condition. Thus, we inhibited DDR by addition of specific ATM and ATR 
inhibitors (KU-55933 and VE 822, respectively) in Zscan4-Emerald ES cells. Flow 
cytometry analysis revealed that the addition of ATR inhibitor could remarkably reduce 
the number of Zscan4-Emerald positive cells both under normal culture condition but also 
upon APH and HU treated conditions (Fig. 7.2B-C). However, ATM inhibitor did not exert 
a significant effect on the reversion of totipotency specific genes; neither in normal nor 
under APH and HU treated circumstances.  
Strikingly, in line with the recent report where constitutive replication stress in 
embryonic stem cells is associated to their short G1 phase (Ahuja, Jodkowska et al. 2016), 
we found that delaying G1 phase by addition of CDC7 inhibitor could significantly restrain 
the Zscan4 positive cells in ESC culture. In addition, similar to ATR inhibition, treatment 
of ESC with CHK1 inhibitor reduced the percentage of Zscan4 positive cells in untreated 
but also APH treated condition (Fig 7.2D). 
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Fig 7.2. ATR mediated DNA replication stress triggered activation of “Zscan4”, a key 
2C-like specific gene in mESC 
A) FACS analysis on sorted Zscan4-Emerald-ESC for DNA damage marker γH2AX. B,C) 
FACS analysis revealed that Zscan4 positive population increased in ESC culture upon 
replication stress induction with APH and HU. ATRi but not ATMi reduced the percentage 
of Zscan4+ population. D) FACS analysis on Zscan4-Emerald ESC indicated that Chk1 
inhibition and G1 phase prolongation (Cdc7i) decreased the percentage of Zscan4+ 
population. 
 
Of note, the number of Zscan4 positive population both under normal condition and 
upon APH treatment, clearly correlated with the number of γH2AX positive cells (Fig. 7.3) 
as in normal culture condition higher proportion of cells were negative for both γH2AX 
and Zscan4 while upon APH treatment, γH2AX and Zscan4 positive populations were 
significantly increased. Importantly, ATR inhibition (but not ATM) dropped the 
percentage of γH2AX and Zscan4 positive populations back to the control level. (Fig. 7.3). 
 
 
 
 
 
 
 
 
 
 
 
Fig 7.3. FACS analysis on Zscan4- Emerald ESC showing the percentage of γH2AX+ 
population, upon treatment with APH and/or ATRi or ATMi. 
DAPI
yH
2A
X
APH																											APH+ATRi APH+ATMi
35.4% 8.5% 28.9%
CNT																												ATRi ATMi
0.8% 0.2% 0.4%
  
 
 
68 
Next, we exposed ESC to the increasing dosage of aphidicolin (APH), hydroxyurea 
(HU) and ultraviolet light (UV) which could activate DNA damage response pathways. 
Strikingly, qPCR and FACS analysis showed that the expression of Zscan4 and MuERV-L 
were significantly upregulated upon all treatments in a time and dosage-dependent manner 
in several independent ESC lines (Zscan4- emerald, E14 and R1) (Fig 7.4A-F). Finally, we 
found that APH treatment do not alter the expression of MuERV-L in mouse embryonic 
fibroblast (MEF) lines with distinct genetic backgrounds (C57BL/6 and 129 strains). 
Moreover, Zscan4d expression was not detectable using qPCR in these MEF lines, 
suggesting that the activation of totipotency related genes could be cell type specific (Fig 
7.4 G).  
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Fig 7.4. Wide range of replication stress inducing agents in PSC trigger activation of 
key totipotency genes in dosage dependent manner. 
A,B,C) FACS analysis on Zscan4-Emerald ESC for Zscan4-GFP-Emerald expression upon 
treatment with various concentrations of APH, HU and UV. D,E) qPCR for MuERV-L, 
one of the main 2C-sepecifc gene on E14 lines treated with APH or HU. F) FACS analysis 
on Zscan4 ESC showed the time and concentration dependent increase in Zscan4 positive 
population. G) qPCR results showed that expression of MuERV-L is not altered upon APH 
treatment in MEF cells even at higher concentrations. (Zscan4 is not detected by qPCR). 
 
These results overall suggest that emergence of Zscan4 positive cells in ESC 
culture is regulated through ATR-mediated DNA damage response (Fig 7.2-7.4). 
 
7.2. Aphidicolin treatment reactivated the transcriptional signature of 2C-like specific 
genes, through ATR dependent pathway. 
Next, to understand if activation of DNA damage response could result in global 
transcriptional alterations similar to that of 2 cell-stage embryos, we performed global gene 
expression profiling on E14 and R1 cells (two established ESC lines) upon aphidicolin 
treatment. Analysis of differentially expressed genes (DEGs) (False discovery rate (FDR)-
adjusted P-value<0.05) identified 74 upregulated genes with more than two-fold changes 
in gene expression upon APH treatment, and only 9 downregulated genes, which is in 
agreement with general openness of the chromatin in totipotent state (Ishiuchi, Enriquez-
Gasca et al. 2015) (Fig 7.5).   
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Fig 7.5. Microarray heatmap analysis showed upregulation of genes rather than  
downregulation upon APH treatment, in line with general openness of chromatin in 
totipotent-like state. 
To understand how many of the identified differentially expressed genes (DEGs) 
overlap with those specifically expressed in 2C embryos or 2C-like cells, we compared our 
DEGs (APH treated condition v.s. CNT) with those of previously published datasets 
(Macfarlan, Gifford et al. 2012). Through such comparison, we found that 46 out of 83 
(55%) DEGs overlap with 2C-specific genes that are previously identified by Macfarlan, et 
al in 2012 (Fig. 7.6).  
 
Fig 7.6. APH treatment reactivated transcriptional signature of 2C-like specific genes, 
through ATR dependent pathways. 
Comprehensive heatmap analysis indicated that APH treated ESC have a strong 
enrichment for 2C-specific genes and the large portion of these totipotency related genes 
were rescued through ATR inhibition. 
 
 
Next, I validated the most important 2C-like related genes found to be upregulated 
in previous works (Zalzman, Falco et al. 2010, Macfarlan, Gifford et al. 2012, Ishiuchi, 
Enriquez-Gasca et al. 2015) including GM4340, Gm12794, Zscan4 family genes (Zscan4c, 
Zscan4d and Zscan4-Total), Tcstv3, Tdpoz3 and Eif1a through qPCR assay (Fig 7.7 A, B).   
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Fig 7.7. Validation of Microarray results by performing qPCR. 
A,B) qPCR results showed over expression of several key totipotency genes in APH 
treated ESCs. 
 
 
Two cell (2C)-like cells have been shown to reduce the expression of the 
pluripotency markers at the protein but not transcriptional level (Macfarlan, Gifford et al. 
2012, Ishiuchi, Enriquez-Gasca et al. 2015). Here, I confirmed that Zscan4 expressing ESC 
are negatively stained for Oct4 and Nanog pluripotency markers (Fig 7.8E). Thus, in order 
to understand if DNA damage induced cells share such features with the 2C-like cells, we 
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checked the expression of the canonical pluripotency markers upon APH treatment. In 
agreement with previous publications, we found a mild down regulation of Nanog, Pou5f1 
(Oct4) upon APH treatment by immunostaining (Fig 7.8B). However, no significant 
alterations in the expression of pluripotency related (Sox2, Nanog and Pou5f1) or germ 
layer specific (Gata6, Wt1 or Pax6) genes were observed at the transcriptional level 
suggesting that these cells are not biased to differentiate toward germ layer-specific 
lineages under replication stress (Fig 7.8C-D). Of note, replication stress induced 
totipotent-like cells (RSIT-LC), gained flat-like morphology, which was distinct from very 
compact and multilayer culture of untreated mESC CNT (Fig 7.8A) consistent with 
previous findings (Amano, Hirata et al. 2013, Ko 2016). 
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Fig 7.8. Characterization of replication stress induced 2C-like cells.  
A) Wide field images showing morphological changes in APH treated ESC versus 
untreated control. B) Immunostaining for pluripotency markers on Zscan4-emerald ESC 
showed that the expression of Nanog and Oct4 is mildly decreased upon APH treatment. 
C) qPCR results in E14 and R1 ESC lines, revealed that there was no significant alteration 
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of pluripotency genes at mRNA level. D) mRNA level in both E14 and R1 ESC lines 
showed that the expression of three germ line specific markers upon aphidicolin treatment 
was comparable to untreated control. E) Immunostaining results illustrated that Zscan4-
positive 2C-like cells do not express Nanog and Oct4 at protein level (NS=not significant, 
each condition was compared to the corresponding control).   
 
Next, we aimed to nail down the contribution of ATR on the global transcriptional 
reversion of replication stress induced 2C-spesific genes. Of note, the geneset enrichment 
analysis confirmed a robust silencing of DNA repair signaling pathway upon addition of 
specific ATR inhibitor (Fig 7.9A). Moreover, we also found activation of UV response 
related gene categories, which could further indicate the activation of replication stress 
upon APH treatment.  Strikingly, the heatmap analysis identified considerable portion 54% 
(25 out of 46) of genes which has reverted their expression back to the level of control 
condition, upon addition of ATR inhibitor (Fig 7.6). In addition, qPCR results for MuERV-
L and Zscan4d genes validated the effect of ATR inhibition on restraining the expression 
of 2C- specific genes, upon treatment with either APH or HU (Fig 7.9B-E).  
 
 
 
 
 
 
 
 
 
  
 
 
75 
 
Fig 7.9. Expression of key totipotency genes are regulated through ATR dependent 
replication stress response  
A) Camera heatmap analysis. B-E) qPCR data representing that ATR inhibitor rescued the 
expression of Zscan4d and MuERV-L, two key 2C specific genes upon APH and HU 
treatment in E14 and R1 ESC.  
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7.3. ATR Seckel ESC have significantly lower expression level of totipotency genes 
Next, in order to confirm that ATR inhibition negatively regulates the reactivation 
of 2C-like genes and to exclude any unspecific inhibitory effect of ATRi that is used in this 
study, we aimed to generate ATR deficient ESC and since complete ablation of ATR is 
embryonic lethal we aimed to establish ATR Seckel ESCs from ATR Seckel mice that 
have been originally generated by Capetillo group. To this aim, two heterozygous mouse 
for ATR Seckel allele were crossed and ESC were isolated at embryonic day 3.5 (E3.5). 
Genotyping results showed that among nine isolated ESC lines, two were homozygous for 
ATR Seckel that were used for further analysis (Fig 7.10A). Of note, we did not observe 
any significant differences in the expression of key pluripotency genes in ATR Seckel ESC 
with respect to wild type controls (Fig 7.10 B). Expectedly, immunoblot results showed 
that the level of ATR protein in ATR Seckel ESCs is markedly decreased in comparison to 
WT controls. Moreover upon APH treatment, the level of phospho-chk1 protein (S345) 
was significantly lower in ATR seckel ESCs with respect to wild type controls. The 
reduction of ATR protein in Seckel ESCs was accompanied by the extensive karyotype 
abnormalities in these cells (Fig 7.10C-D). 
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Fig 7.10. Characterization of ATR Seckel ESC. 
A) ATR Seckel ESC genotyping. (330bp band=WT, 545bp band=ATR Seckel (*). B) 
Immunostaining for pluripotency markers in WT and ATR Seckel ESCs. C) Karyotyping 
analysis showed extensive aneuploidy in ATR Seckel ESC with respect to wild type cells. 
D) Western blot showing the expression level of ATR and p-Chk1 proteins in two WT and 
two ATR Seckel lines.  
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Importantly, the qPCR results in two ATR Seckel and two control lines validated 
the microarray data for a large panel of 2C-like specific genes, excluding any possible 
unspecific inhibitory effect of ATR inhibitor on relevant pathways. Of note, similar to 
inhibitory impact of ATRi on expression of totipotency genes in ESC under normal culture 
condition, APH treatment on ATR Seckel ESC led to the milder increase of 2C-like genes 
expression unlike normal wild type ESC (Fig 7.11A-B). These data collectively suggest 
that activation of ATR-dependent DNA damage response pathway could trigger the global 
reactivation of totipotency gene network and that ATR inhibition exerts a robust 
suppressive impact on such transcriptional alterations.   
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Fig 7.11. Expression of key totipotency genes upon replication stress in ATR Seckel 
ESC 
A,B) qPCR analysis for expression of totipotency genes at mRNA level in ATR Seckel 
lines with respect to WT control (WT=wild type, Sec=ATR Seckel). 
 
Previous reports demonstrated that 2C-specific genes were increased in mutant ES 
cells lacking the histone lysine-specific demethylase gene Kdm1a (also known as LSD1), 
chromatin assembly factor-1 (CAF-1), H3K9 histone methyltranferase G9a, KRAB 
(Kruppel- associated box)-associated transcriptional repressor Kap1 and ten-eleven 
translocation (TET) proteins (Macfarlan, Gifford et al. 2012, Maksakova, Thompson et al. 
2013, Rowe, Friedli et al. 2013, Lu, Liu et al. 2014, Ishiuchi, Enriquez-Gasca et al. 2015). 
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Thus, to test whether replication stress could activate the expression of 2C-like genes 
through interacting with similar pathways, we compared the transcriptome of RSIT-LC 
with those published datasets. This analysis revealed that overlap of DEGs in RSIT-LC 
with Caf1 KO cells (23 out of 83 genes) but not with Kap1, Lsd1 or G9a, TET3KO mutant 
cells. Of note, 48% of the shared DEGs in Caf1 were transcriptionally reverted by addition 
of ATR inhibitor (data not shown). However, the small number of overlapping genes 
between RSIT-LC DEGs and those indicated above, collectively suggest an additional 
mechanism by which replication stress induces expression of totipotency related genes. 
 
7.4. Replication stress increases the transition to 2C-like cells  
The flow cytometry analysis on Zscan4-Emeraled ESC showed that the 
upregulation of Zscan4 is accompanied by increase in the percentage of the Zscan4 
positive population suggesting that there is a significantly higher fraction of 2C-like cells 
with respect to the normal embryonic stem cells in culture after treatment with APH. 
However, this could be for instance due to changes in division and death rates of Zscan4 
positive and negative cells (such as decreased survival of Zscan4-negative cells, or an 
increase in the division rate of Zscan4-positive cells), rather than alterations in the 
switching rate between the negative and positive states (Fig 7.13A). Thus, to exclude if the 
expression of key 2C-like specific genes is due to depletion of Zscan4 negative population, 
which could lead to the preferential enrichment of the pre-existed Zscan4-positive 
population upon replication stress, we first evaluated the casapase3 expression in Zscan4 
positive and negative population to check if Zscan4 negative population are more prone to 
cell death with respect to Zscan4 positive cells. Interestingly, in line with higher load of 
replication stress in Zscan4 positive population under normal culture condition, we found 
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6-fold increase in the activation of caspase-3 in Zscan4 positive population with respect to 
Zscan4 negative cells. Importantly, we found a higher ratio of caspase-3 positive cells 
within zscan4 positive population upon low (0,3uM) and high (6uM) concentration of APH 
(Fig 7.12), which could exclude the higher susceptibility of Zacan4 negative population to 
undergo apoptosis upon DNA replication stress. In addition, these results suggest that 
Zscan4+ cells are more susceptible to undergo apoptosis and it is unlikely that replication 
stress could selectively enrich the culture in the favor of Zscan4+ population. 
 
 
 
 
 
 
 
 
 
 
Fig 7.12. FACS analysis for Caspase3 apoptosis marker in Zscan4 positive and 
negative populations after treatment with APH at two distinct concentrations. 
 
Next, to further consolidate these results, we exposed FACS sorted positive and 
negative Zscan4 cells to APH. Next, we counted cells every 24 hrs and checked their 
Zscan4 expression by FACS analysis daily up to 4 days. Therefore, based on the 
experimental data we employed a theoretical model with stochastic events of cell division, 
cell death, and switching rates (see Materials and Methods) (Fig 7.13B,C). The rates of 
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switching between positive and negative states in the control conditions were fixed by 
fitting the model against the experimental data (Fig 7.13B). Fig 7.13C shows that the null 
hypothesis in which these rates remain the same in the treated condition requires a large 
(more than two-fold) increase in the growth rate of APH-treated Zscan4-positive cells with 
respect to the Zscan4-positive population in untreated condition. In other words, the only 
condition in which	we could exclude the contribution of transition from Z- to Z+ state in 
enrichment of Zscan4+ population is if Z+ cell divide more that 2.5 fold faster upon APH 
treatment with respect to Z+ cells in control condition.  This corresponds to an extremely 
unrealistic situation and is not supported by our experimental data. Overall, these results 
support that APH increase the switching rate of Zscan4 negative population toward Zscan4 
positive ones. 
 
 
 
 
 
 
 
 
 
 
 
Fig 7.13. Mathematical model with stochastic process of cell division, death, and 
switching showed that the observed increase in Zscan4-positive cells in APH treated 
culture is due to the change in switching rates from Z- to Z+ sates. 
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The model is expressed in terms of four rates: the net growth rate q+ (representing 
cell division and cell death) of positive cells, the net growth rate q- of negative cells, the 
switching rates k+ and k-. The net growth rates are equal to a duplication rate minus a 
death rate for the specific cell type. B,C) All model parameters are fixed in the control 
experiment, where the fraction of positive cells (circles) converges to a long-time value 
around 5%. The curves are model fits, yielding k+ = 0.9±0.1, k- = 0.14±0.03. Supposing 
the switching rates remain the same in the treated culture, the experimental data (circles) 
can be realized in the model only if the net growth rate q+ of positive cells is 2.5±0.5 times 
larger than in the control, which is highly unrealistic. Different curves are obtained for 
increasing (from bottom to top) values of q+, starting from the value in the control. The 
growth rate of negative cells, q-, is fixed by cell counts at t=1d. 
Next, in order to understand the impact of transient activation of replication stress 
response on generating SSB or DSB, I stained ESC with 53BP1 and H2aX, 24 hrs post 
treatment but also after three passages in fresh media. Although the number of 53BP1 
nuclear bodies increased up to 3 fold 24 hrs post APH treatment, I did not find any 
significant change of that after 3 passages of ESC (Fig 7.14A and B) suggesting that the 
transient activation of replication stress response by APH does not lead to permanent 
lesion on ESC genome probably due to the activation of DNA repair genes. Importantly, I 
also did not observe any significant alteration in the number of co-localized H2AX and 
53PB1 nuclear bodies suggesting that transient treatment with APH does not result in DSB 
formation in ESC (Fig 7.14C and D).  
  
 
 
 
  
 
 
84 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7.14. Immunostaining for γH2AX and 53BP1 foci in ESC. 
A-D) Immunofluorescence showing 53BP1 and γH2AX nuclear bodies in APH treated 
ESC versus control 24 hrs post treatment and after three passages. The bar plots 
representing the average number of 53BP1 and γH2AX nuclear body per cell in each 
condition (n=10 field/condition). 
 
7.5. ATR activated 2C-like cells gain expanded developmental potential 
Our results so far indicated that ATR activated ESC exhibit similar transcriptional 
profile and characteristics of 2-cell-stage embryos. Strikingly, computational gene-sets 
analysis of APH vs CNT through molecular signature database (MSigDB), identified a 
strong and highly significant enrichment in placenta-related pathways which are robustly 
suppressed upon ATR inhibition (Fig 7.15A). 
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In addition, gene expression results also revealed that the activation of some key 
placenta related genes upon replication stress in PSC including Fstl3, Dgka, Egfr, GPX3, 
Slc7a8, Eng, Cyr61, Adm, Scn1b, Emp3, Anpep, Cryab and Hspb2. some of which are 
interestingly involved in exosome formation and angiogenesis (such as Dgka, Eng or 
Egfr), the critical pathways that are potentially exploited by placenta to gain migratory, 
invasive and immune suppressive features (Fig 7.15B)  
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7.15. A global activation of placenta related gene categories upon APH treatment. 
A) The Volcano plot shows a strong and highly significant upregulation of the placenta 
related gene categories upon APH treatment while ATR inhibitor reverted them back to the 
control level (all the gene categories above red line are significant and the categories 
upregulated are in the right part of the panel, while the gene categories on the left are 
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downregulated). B) Expression of placenta related genes in E14 and R1 ESC after 
treatment with APH at mRNA level. 
 
These results overall suggest that RSIT-LC have gained expended development 
potency and thus are more prone to be differentiated to extra-embryonic tissues. Hence, we 
asked if ATR activation could promote differentiation toward trophectoderm lineage. To 
this aim, both ATR Seckel and control ESC cells (upon treatment with APH) were 
differentiated in vitro toward trophoblast-like stem cells for three days followed by further 
differentiation to giant trophoblast -like cells upon withdrawal of FGF4 and heparin for 3 
additional days (see Material and Method) (Abad, Mosteiro et al. 2013). Interestingly, 
along with higher number of differentiated cells in APH treated control cells, qPCR results 
revealed the highest expression of main trophoblast stem cell specific marker “Cdx2” in 
ATR proficient condition while ATR Seckel cells did not significantly upregulate this 
marker in the absence of APH (Fig 7.16).   
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Fig 7.16. Replication stress induced 2C-like cells gain expanded in vitro 
developmental potential.  
A-D) Phase contrast images and qPCR results of E14-WT and ATR Seckel ESC upon 
aphidicolin treatment. qPCR results revealed activation of trophoblast specific marker, 
Cdx2 upon activation of ATR. D) Cdx2 expression is significantly hampered upon 
differentiation of ATR Seckel ESC toward giant trophoblast-like cells with respect to WT 
ESC.  
 
Next, to understand if these cells have also gained distinct functional characteristics 
to give rise to extra-embryonic tissues along with inner cell mass derived lineages, Zscan4-
emerald ESC were infected with a lentivirus encoding mCherry protein (from 
constitutively active EF1a-promoter (which is reported not to be silenced in ESC unlike 
CMV promoter), sorted for mCherry expression and subsequently treated with APH. Next, 
we injected five to eight cells into morula-stage embryos taking advantage of laser assisted 
microinjection technique (experimental set up is shown in Fig 7.17A) and 24 hrs post 
injection the contribution of cells into inner cell mass and trophectoderm layer were 
analyzed (Fig 7.17B). Interestingly, in 7 out of 35 (20%) chimeric embryos, APH-induced 
2C-like cells contributed to both ICM but also the trophectoderm layer of the blastocysts, 
while none of the un-treated CNT cells could contribute to the trophectoderm lineage (Fig 
7.17B). This results suggest that the developmental potential of ATR activated cells 
includes embryonic plus extra-embryonic tissues in contrast to normal ESC, which are 
mostly restricted to generate embryonic cell types. 
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Fig 7.17. Replication stress induced 2C-like cells gain expanded in vivo developmental 
potential.  
A) A scheme showing the experimental setup for laser-assisted cell injection into morula 
stage. B) APH-treated cells contributed to the ICM and trophectoderm layer of the 
blastocysts unlike normal ESC.  
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7.6. Somatic cell reprogramming in the presence of Cdc45 
 
Although reprogramming to pluripotent state has been demonstrated by Yamanaka 
in 2006, to our knowledge, no data on in vitro reprogramming of somatic cells to 
totipotent-like state is reported yet. In order to understand if a mild activation of DNA 
replication stress response during reprogramming could elevate the expression of key 
totipotency genes in emerging iPSC colonies, we searched for the replication factors that 
are known to induce replication stress when they are overexpressed. We chose Cdc45, an 
essential replication initiation factor and Cdc6, one of the key components of pre-
replicative complex as their over-expression have been shown to induce replication stress 
previously (Bartkova, Rezaei et al. 2006, Srinivasan, Dominguez-Sola et al. 2013). Prior to 
test the effects of these replication factors during reprogramming, we examined the impact 
of their over-expression in E14 cells. To this aim, Cdc45 and Cdc6 cDNA were cloned into 
a Flag-tagged lentivector with EF1α promoter and then E14 cells were infected and 
subsequently underwent puromycin selection step (the overexpression of Cdc45 and Cdc6 
were confirmed by western blot, fig 7.18A). Although Cdc45 and Cdc6 over-expressing 
ESCs maintained their typical morphology in culture (Fig 7.18B), qPCR assay revealed 
that the expression of the key two-cell embryo-specific genes including Zscan4, Gm12794, 
Gm4340 and MuERV-L are upregulated in Cdc45 and Cdc6 infected cells versus empty 
vector (EV) infected control condition (Fig 7.18C,D). However, overexpression of these 
factors on mouse embryonic fibroblast (MEF) did not alter the expression of MuERV-L 
gene (Zscan4d was not expressed in MEF cells), suggesting the specific role of these genes 
in pluripotent stem cells (Fig 7.18E).  
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Fig 7.18. Overexpression of Cdc45 and Cdc6 elevated the expression of 2C-specific 
genes in E14 ESC line.  
A) Western blot for Cdc45 and Cdc6 on E14 cells after infection B) Bright field images of 
Cdc45, Cdc6 overexpressing E14 cells C) qPCR assay for some key totipotency genes on 
Cdc45, Cdc6 over expressing E14 cells. D) Expression level of Cdc45 and Cdc6 in 
infected ESC. E) mRNA expression level of MuERV-L in MEF cells under empty vector 
(EV) control, Cdc45 and Cdc6 overexpressing conditions (EV=empty vector control). 
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Next, we asked if over-expression of Cdc45 during reprogramming could further 
reprogram the somatic cells back to the earlier embryonic stages. To this aim, we first 
established somatic cell reprogramming (Fig 7.19A) using low passage Oct4-GFP MEFs 
that are expressing GFP under the control of Oct4 promoter and upon acquisition of 
pluripotency cells turn in to green as it is depicted in fig 7.19B. The picked colonies were 
positively stained for ALP and other pluripotency markers such as Oct4, SSEA1 and Tra1-
60 (Fig 7.19C-D). 
Next, we co-infected Cdc45 with reprogramming cocktail (Oct4, Sox2, c-Myc and 
Klf4) and followed the established reprogramming protocol. Upon withdrawal of 
doxycycline bona fide iPSC colonies were picked and examined to identify colonies 
harboring Cdc45 expressing vector. Out of twelve colonies, we could identify two clones 
(Cdc45-3 and Cdc45-9), which had a higher level of Cdc45 both at protein and mRNA 
level (Fig 7.19E and 7.21A). These results were also confirmed by blotting for anti-Flag 
antibody (Fig 7.19F). 
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Fig 7.19. Activation of mild replication stress during somatic cell reprogramming 
resulted in elevation of totipotency genes in iPSC colonies. 
A,B) Schematic view of somatic cell reprogramming protocol d) Expression of 
endogenous GFP upon reprogramming of Oct4-GFP MEFs. C,D) Reprogrammed colonies 
are positively stained for ALP and pluripotency markers. E,F) Identification and 
verification of Cdc45 over-expressing iPSC colonies.  
 
As shown in Fig 7.20A besides maintenance of typical iPSC morphology, Cdc45 
induced iPSC colonies were positively stained for key pluripotency markers such as ALP, 
Oct4, Nanog and SSEA1. Moreover, qPCR results confirmed that Cdc45 overexpressing 
iPSC express pluripotency genes quite at the homogenous level (Fig 7.20C). Next, to 
exclude the possibility that Cdc45 induction favors a certain cell lineage commitment, we 
performed in-vitro differentiation assay through the formation of embryoid bodies. These 
results showed that Cdc45-iPSC are able to contribute to the three main embryonic 
lineages namely endoderm, mesoderm and ectoderm by activation of key lineage specific 
transcriptional factors similar to the control iPSC. This activation was also accompanied by 
the robust repression of key pluripotency genes upon differentiation (Fig 7.20 B-D).  
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Fig 7.20. Characterization of Cdc45 overexpressing iPSC. 
A) Immunofluorescence for pluripotency markers on control and Cdc45 overexpressing 
iPSC colonies. B) In-vitro differentiation of control and Cdc45 overexpressing iPSC 
colonies to embryoid bodies C) qPCR assay results showed that pluripotency markers were 
silenced upon induction of differentiation in all iPSC clones D) qPCR for endoderm 
(Gata6), ectoderm (Pax6) and mesoderm (Wt1) differentiation markers on control and 
Cdc45 over expressing colonies. 
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Then we performed qPCR on Cdc45 overexpressing colonies for some of 
totipotency specific genes where the results not only demonstrated upregulation of some 
key 2C-like genes in Cdc45 overexpressing iPSC, but more importantly revealed that there 
is a Cdc45 dosage dependent gene expression pattern for some of the key 2C-like specific 
genes such as MuERV-L, Zscan4 and GM12794 (Fig 7.21) (Macfarlan, Gifford et al. 
2012, Ishiuchi, Enriquez-Gasca et al. 2015). These results overall suggest that Cdc45 not 
only induce expression of totipotency genes on already established PSCs but its expression 
could also generate iPSC which express 2C-like specific genes. 
 
 
 
 
 
 
 
 
 
 
Fig 7.21. A, B) qPCR results for key totipotency genes in Cdc45 overexpressing 
colonies. 
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8. Discussion 
Several studies show that mESC exhibit high level of γH2AX in the absence of 
measurable numbers of DNA double-strand breaks. Importantly, the high numbers of 
endogenous γH2AX foci in pluripotent mES cells was found to be dependent on the 
activity of the apical checkpoint kinase ATM or DNA-PK and notably, is not associated 
with the double- strand break (DSB) marker 53BP1 (Ziegler-Birling, Helmrich et al. 2009).  
A recent interesting study from Lopes lab, shows that H2AX phosphorylation in 
cultured ESCs and mouse embryos is instead dependent on Ataxia telangiectasia and Rad3 
related (ATR) and is associated with chromatin loading of the ssDNA-binding proteins 
RPA and RAD51.  Moreover, their results reveal that ESCs display massive accumulation 
of ssDNA gaps, reduced fork speed and frequent fork reversal through single-molecule 
analysis of replication intermediates. Interestingly, they have found that delaying the G1/S 
transition in ESCs allows formation of 53BP1 nuclear bodies and suppresses ssDNA 
accumulation, fork slowing and reversal in the following S-phase suggesting that a short 
G1 phase imposes constitutive replication stress and fork remodeling in mouse embryonic 
stem cells (Ahuja, Jodkowska et al. 2016). 
Despite of reported constitutive DNA replication stress in ESC, the mutation 
frequency in ES cells is significantly lower than that in mouse embryonic fibroblasts This 
could be since ESC are critical for embryo formation as they ensure the lifetime 
maintenance of any tissues upon differentiation. Thus, any misrepair of DNA damage in 
ESC can be transmitted to multiple cell lineages, thereby compromises tissue integrity and 
function. That is why ESC has to come up with several modifications in DNA damage 
response, which accommodate dynamic cycling and preservation of genetic information. 
For instance, mESC mostly utilize the extremely precise repair mechanism i.e. HRR to 
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repair their DNA with respect to differentiated cells that use NHEJ (Lin, Chao et al. 2005, 
Tichy and Stambrook 2008, Serrano, Liang et al. 2011, Schneider, Pellegatta et al. 2013, 
Santos, Faryabi et al. 2014). 
Interestingly, the exceptional genomic stability of mESC has been linked to 
Zscan4, which has been discovered as a specific marker for two-cell embryo and 2C-like 
ES cells. Of note, about 5% of ES cells express Zscan4 at a given time, but nearly all ES 
cells activate Zscan4 at least once during nine passages that is associated with rapid 
telomere extension through telomere recombination and upregulation of meiosis-specific 
homologous recombination genes. On the other hand, Zscan4 knockdown ESC are found 
to have shorter telomeres, increased karyotype abnormalities and spontaneous sister 
chromatid exchange, which is also accompanied by slowing down cell proliferation until 
reaching crisis by passage eight. Overall, these findings show a unique mode of genome 
maintenance in ES cells (Zalzman, Falco et al. 2010, Amano, Hirata et al. 2013). 
Here, my results show that expression of Zscan4 is regulated by ATR, a main 
component of DNA damage response pathway, which is activated upon DNA replication 
stress. Importantly, further activation of replication stress response via agents such as 
APH, HU and UV that challenge accurate DNA replication could elevate the expression of 
Zscan4 in a time and concentration dependent manner. Importantly, activation of Zscan4 
was reverted back to the basal level upon addition of ATR and CHK1 inhibitors. These 
results overall provide a new mechanism through which ESC copes with constitutive 
replication stress to maintain its genomic stability.  
As all living organisms are constantly exposed to genotoxic stress, their genome 
needs to be repaired to preserve the vital information. DNA damage induces a robust 
response mediated by the DNA damage repair network at the center of which there are 
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ATM and ATR proteins, which sense DNA double strand breaks (DSBs) and DNA single-
strand breaks (SSBs) to recruit proteins operating in the repair systems. DDR-mediated 
cellular outcomes may range from cell death by apoptosis, transient cell cycle arrest 
followed by repair of DNA damage; to cellular senescence caused by the persistence of 
unrepaired DNA damage (Sulli, Di Micco et al. 2012).   
In response to genotoxic stress and/or inappropriate microenvironment, mESCs 
undergo either apoptosis or differentiation, thus removing damaged cells from the 
pluripotent pool and eliminating any cell at risk of malignant transformation, while somatic 
cells undergo apoptosis or cellular senescence to limit the risk of malignant transformation 
(Tichy and Stambrook 2008, Sulli, Di Micco et al. 2012). 
Though DNA damage induced cellular differentiation and apoptosis has been 
frequently reported in stem cells, To our knowledge, here for first time we report that 
replication stress in ESC, could lead to the transition to more primitive totipotent-like state 
followed by the global activation to 2C-like transcriptional network (Schneider, Pellegatta 
et al. 2013, Santos, Faryabi et al. 2014). More importantly, we found that the activation of 
totipotency related genes is mediated by ATR, the key components of DDR pathways 
whose specific inhibition, represses the reactivation of 2C-like transcriptional profile under 
normal condition but also in the presence of replication stress inducing agents. 
Aneuploidy is commonly seen in human pre-implantation embryos, most 
particularly at the cleavage stage. However, some mosaicisms, such as copy number 
variations could be compatible with live birth. For example, healthy euploid newborns 
have been recently reported upon intrauterine transfer of mosaic aneuploid blastocysts 
pointing to presence of some self-correction mechanisms to repair aneuploidies (Bazrgar, 
Gourabi et al. 2013, Greco, Minasi et al. 2015). Several explanations have been proposed 
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for self-correction of aneuploidies during embryonic development, including allocation of 
the aneuploidy in the trophectoderm, cell growth advantage of diploid cells in mosaic 
embryos, lagging of aneuploid cell division, and the abundance of DNA repair gene 
products (Bazrgar, Gourabi et al. 2013). Of note, in 2015 Ko lab reported evidences for 
Zscan4 role in correction of chromosomal abnormalities in human fibroblast samples from 
Dawn and Edwards syndrome individuals (though the underlying mechanism is not shown) 
suggesting that ZGA in particular activation of Zscan4 event could be vital to keep the 
early embryonic cell genome intact (Amano, Jeffries et al. 2015, Ko 2016). 
 Consistent with these evidences, my findings show that activation of DNA damage 
response pathways reprograms the PSC to more primitive and developmentally potent 
stage by activation of totipotency gene network. Strikingly, I found that replication stress 
induced ESC, activated global transcriptional network of placenta related genes in an ATR 
dependent manner. In support of this, higher efficiency in differentiation toward giant 
trophoblast-like cells was found upon activation of replication stress response. Finally, 
replication stress induced ESC found to contribute more efficiently to trophectoderm layer 
of blastocysts upon microinjection into early morula in comparison with CNT ESC. These 
results overall suggest that replication stress increase the transition of ESC to 2C-like state 
which is highly enriched for specific DNA repair proteins such as Zscan4 but also activates 
trophectoderm differentiation program to sequester cells to the extra-embryonic 
compartment (Zalzman, Falco et al. 2010, Amano, Jeffries et al. 2015) and thus minimize 
the contribution of the damaged cell to embryos whole body mass.   
The critical involvement of ATR to activation of totipotency network but also 
trophoblast differentiation, were confirmed in ATR Seckel ESC. Besides, validating the 
specificity of the ATR inhibitor used in the study, our findings shed light on the possible 
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mechanism that could lead to the premature aging phenotype in ATR Seckel mice as 
reported by Murga et al. In support of our finding, authors have reported accumulation of 
necrotic areas and overall loss of cellularity in mutant placentas that could also contribute 
to the dwarf phenotype regardless of intrinsic developmental defects (Murga, Bunting et al. 
2009).  
Although reprogramming to pluripotent state has been demonstrated by Yamanaka 
in 2006, to my knowledge, no data on in-vitro reprogramming somatic cells to totipotent-
like cells is reported yet.  In order to understand if the mild activation of replication stress 
response could reprogram the somatic cells directly to totipotent-like cells, first I looked 
for factors that upon over-expression could activate replication stress response in ESC as 
somatic cell reprogramming in the presence of agents such as APH or HU in long term is 
not practically possible.  
Here, for the first time, I found that overexpression of some factors which are 
previously shown to activate replication stress response, such as Cdc45/6, not only elevate 
the expression of totipotency genes on established ESC but also Cdc45 overexpression 
could elevate the expression of 2C-like genes in emerging iPSC. Of note, I did not observe 
any atypical tendency in self-renewal or differentiation potency of Cdc45 overexpressing 
iPSC as they expressed canonical pluripotency markers and directed toward three main 
embryonic germ layers upon differentiation. Yet, my finding showed that Cdc45 
overexpressing colonies elevate the expression of several members of Zscan4 gene family, 
which are associated with genomic stability of PSC. However, additional experiments are 
needed to understand if these factors are exerting their effect through similar mechanism of 
replication stress inducing agents.  
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In conclusion, our findings not only shed light on exogenous and endogenous 
stimuli that could contribute to the genome plasticity of PSC but also provide an important 
insight on the critical mechanisms that PSC exploit to cope with genotoxic stress.   
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